ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0000257.1|Prodigiosin_1 # 1 # 351 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.781	BGC0000257.1|Prodigiosin_1 	1	351	+	Loose	700	22.7126	PDC-87	32.65	3004350	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	GGGCCCGCCGTGTCCTCCCTCGGGCTGCTGGGGGAGGGCAGCGGATTCGGCTTTTCGGCCGATGTGCCGGGGCGCCGGGGCGCGGATGCTGGAGGCATGACTACCGCAGCCTTCCACCAGCCAGTGTCCGACGCCGCCCCGGGCGCCACCGCCCTCGGCGCGGGCGTCCCCGGGCAGGCGCGCCGGCATCCGCGGCACCTGCTCGGCAGCGCCCTGCGGGCGGCGCGGGTCTTCGCCGGGGCGACGTTCAGCGTCGCCGTGCTCGGTCAGTACGACGGCCGTACGCACGACGTCCGTGGCGCCGTCGTCACCCCGCGCGACGGCGCGCACGACCGCGCGCACGGCCGCTGA	GPAVSSLGLLGEGSGFGFSADVPGRRGADAGGMTTAAFHQPVSDAAPGATALGAGVPGQARRHPRHLLGSALRAARVFAGATFSVAVLGQYDGRTHDVRGAVVTPRDGAHDRAHGR	DEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRDLGLVILANRNYPIAERVKIAYAILSGLEQQAKVPLKR	31.27	gnl|BL_ORD_ID|2539|hsp_num:0	2866		
BGC0000257.1|Prodigiosin_2 # 388 # 1848 # -1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.713	BGC0000257.1|Prodigiosin_2 	388	1848	-	Loose	2300	26.1794	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin	31.15	3003283	protein variant model	S522L, H526T, G523A	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	GTGCAGAGTGACAAGACCCTGCTGCTGGAGGTGGACCACGAGCAGGCGGACGCCTGCCGGCGTGCCATCGCGCCGTTCGCCGAGCTGGAGCGGGCGCCCGAGCACATCCACACCTACCGGGTGACCCCGCTGGGGCTGTGGAACGCGCGGGCCGCCGGGCACGACGCGGAGCAGGTGGTGGACGCGCTGGTCGCGCACTCCCGCTACCCGGTGCCGCACGCGCTGCTCGTCGATGTCGCCGAGACCATGGCCAGGTGCGGCAGGCTGCGGCTGCTCAAGCACCCGGTGCACGGTCTGGTGCTGGAGAGCTCCGACCGCCCGGTGCTGGAGGAGGTCCTGCGGTCGAAGAAGGTCCAGCCGCTGGTGGGCACCCGTATCGACCCGGACACGGTGGCGGTGCACCCGTCGGAGCGCGGGCAGATCAAGCAGACCCTGCTGCGGCTCGGCTGGCCCGCCGAGGACCTGGCGGGCTATGTGGACGGCGAGGCGCACCCCATCGCGCTGCACGAGGACGGCTGGGCGCTGCGGCCTTACCAGACGCAGGCGGTGGAGGGGTTCTGGCACGGCGGCTCCGGCGTGGTGGTGCTGCCGTGCGGGGCGGGCAAGACGCTGGTCGGCGCGGGGGCGATGGCGCAGGCGCGGGCGACCACGCTGATCCTGGTGACGAACACGGTGTCCGCCCGGCAGTGGAAGCACGAGCTGGTGCGCCGCACCTCGCTGACCGAGGACGAGATCGGCGAGTACAGCGGCACCCGCAAGGAGATCCGGCCGGTCACCATCGCCACGTACCAGGTGCTGACGGTGAAGCGGAAGGGGATCTACCCGCATCTGGAGCTGTTCGACTCGCGGGACTGGGGCCTGATCGTCTACGACGAGGTGCATCTGCTGCCGGCGGACTGCGTGGAGGTACGGGTCGACCTCACCGACGCGGAGCGGCTCGCCTACGCCACCGCGGAGACGGAGGAGAAGTACCGCTACTGTGCGACGACGGACACCAAGCGCCGGGTCACGGAGGCGCTGGTGCGGCGGCACGCGGGCGAGCAGACGCTGGTCATCGGGCAGTACATCGACCAGCTGGACGAGCTGGGCGAGCACATCGGGGCGCCCGTCATCAAGGGTGAGACCACGAACGCACGGCGCGAGAAGCTGTTCGAGGCGTTCCGGCAGGGCGAGCTGAGCGTGCTGGTGGTGTCGAAGGTGGCGAACTTCTCCGTCGACCTGCCGGAGGCGACGGTCGCGATCCAGGTGTCGGGCACCTTCGGGTCACGGCAGGAGGAGGCCCAGCGGCTGGGCCGGGTGCTGCGGCCGAAGGCAGACGGGCACGAGGCGCGGTTCTACTCGGTGGTGGCGCGGGACACGGTGGACCAGGACTACGCGGCGCACCGCCAGCGGTTCCTGGCGGAGCAGGGGTACGCGTACCGGATCGTGGACGCGACGGAGCTGCTGGCCGGCGAGGTGTAG	MQSDKTLLLEVDHEQADACRRAIAPFAELERAPEHIHTYRVTPLGLWNARAAGHDAEQVVDALVAHSRYPVPHALLVDVAETMARCGRLRLLKHPVHGLVLESSDRPVLEEVLRSKKVQPLVGTRIDPDTVAVHPSERGQIKQTLLRLGWPAEDLAGYVDGEAHPIALHEDGWALRPYQTQAVEGFWHGGSGVVVLPCGAGKTLVGAGAMAQARATTLILVTNTVSARQWKHELVRRTSLTEDEIGEYSGTRKEIRPVTIATYQVLTVKRKGIYPHLELFDSRDWGLIVYDEVHLLPADCVEVRVDLTDAERLAYATAETEEKYRYCATTDTKRRVTEALVRRHAGEQTLVIGQYIDQLDELGEHIGAPVIKGETTNARREKLFEAFRQGELSVLVVSKVANFSVDLPEATVAIQVSGTFGSRQEEAQRLGRVLRPKADGHEARFYSVVARDTVDQDYAAHRQRFLAEQGYAYRIVDATELLAGEV	MADSRQSKTAASPSPSRPQSSSNNSVPGAPNRVSFAKLREPLEVPGLLDVQTDSFEWLIGSPRWRESAAERGDVNPVGGLEEVLYELSPIEDFSGSMSLSFSDPRFDDVKAPVDECKDKDMTYAAPLFVTAEFINNNTGEIKSQTVFMGDFPMMTEKGTFIINGTERVVVSQLVRSPGVYFDETIDKSTDKTLHSVKVIPSRGAWLEFDVDKRDTVGVRIDRKRRQPVTVLLKALGWTSEQIVERFGFSEIMRSTLEKDNTVGTDEALLDIYRKLRPGEPPTKESAQTLLENLFFKEKRYDLARVGRYKVNKKLGLHVGEPITSSTLTEEDVVATIEYLVRLHEGQTTMTVPGGVEVPVETDDIDHFGNRRLRTVGELIQNQIRVGMSRMERVVRERMTTQDVEAITPQTLINIRPVVAAIKEFFGTSQLSQFMDQNNPLSGLTHKRRLSALGPGGLSRERAGLEVRDVHPSHYGRMCPIETPEGPNIGLIGSLSVYARVNPFGFIETPYRKVVDGVVSDEIVYLTADEEDRHVVAQANSPIDADGRFVEPRVLVRRKAGEVEYVPSSEVDYMDVSPRQMVSVATAMIPFLEHDDANRALMGANMQRQAVPLVRSEAPLVGTGMELRAAIDAGDVVVAEESGVIEEVSADYITVMHDNGTRRTYRMRKFARSNHGTCANQCPIVDAGDRVEAGQVIADGPCTDDGEMALGKNLLVAIMPWEGHNYEDAIILSNRLVEEDVLTSIHIEEHEIDARDTKLGAEEITRDIPNISDEVLADLDERGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGESGKVIGIRVFSREDEDELPAGVNELVRVYVAQKRKISDGDKLAGRHGNKGVIGKILPVEDMPFLADGTPVDIILNTHGVPRRMNIGQILETHLGWCAHSGWKVDAAKGVPDWAARLPDELLEAQPNAIVSTPVFDGAQEAELQGLLSCTLPNRDGDVLVDADGKAMLFDGRSGEPFPYPVTVGYMYIMKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDTVGRVKVYEAIVKGENIPEPGIPESFKVLLKELQSLCLNVEVLSSDGAAIELREGEDEDLERAAANLGINLSRNESASVEDLA	41.47	gnl|BL_ORD_ID|2005|hsp_num:0	1237		
BGC0000257.1|Prodigiosin_4 # 2580 # 2906 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.706	BGC0000257.1|Prodigiosin_4 	2580	2906	-	Loose	750	25.7942	patA	26.39	3000024	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGACACCATCGTCCACCGCATCCGCCTGCGTGACGGCGTACCGCCGGAGCGCTTCGAGCGCTGGGTGCGCGAGACCGACTACGCCACCTGCCCCGAGCTGCCCAGTGTGCTGCGCTTCTCCGTGCACCGGGTCCCCGCGGCGCCGCCCGGCGCGCCGTACCACTCCTTCGAGTTCTTCGAGATCATCGAGGTCAGCAGCCAGGACGCGTTCGCCCGCGACATGGCATCGGACGCCTTCCGGCGGCTGGAGAAGGACTTCGACACGATGGCCGAGGTGACCGACGAGCTCACCGGGCGCCGCATCGGCGCGGGCTACGCCGCCTGA	MDTIVHRIRLRDGVPPERFERWVRETDYATCPELPSVLRFSVHRVPAAPPGAPYHSFEFFEIIEVSSQDAFARDMASDAFRRLEKDFDTMAEVTDELTGRRIGAGYAA	MLIQKIKTYKWQALASLLMTGLMVASSLLQPRYLQEVLGALLTGKYEAIYSIGAWLIGVAVVGLVAGGLNVVLAAYIAQGVSSDLREDAFRKIQTFSYADIEQFNAGNLVVRMTNDINQIQNVVMMTFQILFRLPLLFIGSFILAVQTLPSLWWVIVLMVVLIFGLTAVMMGMMGPRFAKFQTLLERINAIAKENLRGVRVVKSFVQEKEQFAKFTEVSDELLGQNLYIGYAFSVVEPFMMLVGYGAVFLSIWLVAGMVQSDPSVVGSIASFVNYLSQIIFTIVMVGFLGNSVSRAMISMRRIREILDAEPAMTFKDIPDEELVGSLSFENVTFTYPMDKEPMLKDVSFTIEPGQMVGVVGATGAGKSTLAQLIPRLFDPQDGAIKIGGKDIREVSEGTLRKTVSIVLQRAILFSGTIADNLRQGKGNATLFEMERAANIAQASEFIHRMEKTFESPVEERGTNFSGGQKQRMSIARGIVSNPRILIFDDSTSALDAKSERLVQEALNKDLKGTTTIIIAQKISSVVHADKILVLNQGRLIGQGTHADLVANNAVYREIYETQK	19.15	gnl|BL_ORD_ID|1953|hsp_num:0	2081		
BGC0000257.1|Prodigiosin_5 # 2982 # 4187 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.737	BGC0000257.1|Prodigiosin_5 	2982	4187	-	Loose	900	25.409	otr(B)	42.31	3002892	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAACTTCGACTTCGATCCCGAGACCCGGGAGATGCGTGAGATGGTCGTCGGCTTCGCGCGGCGCGAGCTGAACGGCGGGGCGGGCTTCCGCCCCGGCCCCGGCGGCGGTACCGACGAGGCCGCCGCCGACTTCCGGCACCGCTGGCAGCTGGCGGGCAAGCAGGGCATCACCGGCAGCTGCGTCCCGGCGGCGTACGGGGGCAGCGGCCTGGACGCCGTCACCGCCGCCGCGCTGATGGAGGCGCTCGGGCAGGGCTGCACCGACACCGGGTTCGCCTTCTCCGTCGGCGCGCACCTGTTCGCCTCGCTGATGCCGCTGGTGGAGTTCGGCACCGAGGAGCAGAAGCGGCGCTGGCTGCCGGCGCTGTGCTCGGGCGAACGCATCGCCGCGCACGGCATCACCGAGCCGGAGGCCGGCTCCGACGCGCTGAACCTGCGCACCCGCGCCGAACGGCGCGAGGACGGCTATGTGCTCAACGGCGGCAAGTGCTTCACCACCAACGCGCCCGTCGCGGACGTCTTCGTGGTGCAGGCGGCCACCGCGCCCGGCGGCGGCTACTTCGGCCTGACCGCCTTCATCGTGGAGGCCGGCACCCCCGGGCTGACCGTCGGGCCGCCGTACGACAAGACGGGCCTGCACGGCTCGCCGATGGCCGACGTGCACTTCGAGGACTGCCACGTCCCGCTGGACCAGGTGCTCGGCGGCGAGGGCGCGGGCGCCAGCGTCTTCACCTCCTCGATGAAGTGGGAGCGGACCTGCCTGTTCGCCGCCTACCTGGGCACCATGAAGCGGGTGCTCGACGGCACCCTGGCGTACGTGGGCGAGCGCGAGCAGTTCGGCGTCCCGATCGGCAGCAACCAGGCGGTGTCGCACCGGATCGTGGACATGACGCTGCGCTACGAGTCGGCGCGGCTGATGCTGTACAAGGCCGCGCGCGGCCTCGCGGACGGCAGCGACGACGAGATCGCCCCGCCCTCGCCAGCTCGCGGTGAGCGAGGCCGCCTCCAGCTCGGCCTGGACGCCGTGCAGCTGCACGGCGCGCTCGGCATCCTCACCGGCGAGGCGGAGGCGCTGGTGCGGGACGCGATGCCGTCGCGGATCTTCTCCGGCACCAACGAGATCCAGAAGAACAACATCGCCCGCGCCCTGGGCCTGGGCGCGCGCCGCTCCCGCCCGCGCCCGCGCTCCCGCGCGGCCCGCTGA	MNFDFDPETREMREMVVGFARRELNGGAGFRPGPGGGTDEAAADFRHRWQLAGKQGITGSCVPAAYGGSGLDAVTAAALMEALGQGCTDTGFAFSVGAHLFASLMPLVEFGTEEQKRRWLPALCSGERIAAHGITEPEAGSDALNLRTRAERREDGYVLNGGKCFTTNAPVADVFVVQAATAPGGGYFGLTAFIVEAGTPGLTVGPPYDKTGLHGSPMADVHFEDCHVPLDQVLGGEGAGASVFTSSMKWERTCLFAAYLGTMKRVLDGTLAYVGEREQFGVPIGSNQAVSHRIVDMTLRYESARLMLYKAARGLADGSDDEIAPPSPARGERGRLQLGLDAVQLHGALGILTGEAEALVRDAMPSRIFSGTNEIQKNNIARALGLGARRSRPRPRSRAAR	MSSANPGPAGTADQAGGAFTHRQILTAMSGLLLAVFLAALDQTVIATAMRTIADDLHGQTEQAWATTGYLIASVLAMPFYGKLSDIYGRKPMYLISIVVFIGGSVLCGTAGSMWELALFRAVQGLGGGGLMSLPTAVVADLAPVRERGRYFAFLQMAWVVASVAGPLAGGFFAEAGQVFGIDGWRWVFLLNVPLGLLALVTVRKALNLPHERREHRMDVLGAAALALFLVPLLIVAEQGRTWGWGSPAALALFALGAAGLAVFIPVELRRGDEAILPLGLFRRGSIALCSAVNFTIGVGIFGTVTTLPLFLQMVQGRTPTQAGLVVIPFMLGTIASQMVSGKLIASSGRFKKLAIVGLGSMAGALLAMATTGATTPMWGIVLIVLWLGVGIGLSQTVITSPMQNSAPKSQLGVANGASGLCRQIGGSTGIAVLFSVMFAVALGRLADLLHTPRYERLLTDPAITGDPANHRFLDMAESGQGAGINLDDTSLLNGIDARLMQPVTDSFAHGFHIMFLAGGVVLLAGFVMTWFLRELQEETAPEEERPAESGAGAKNGPLPASDA	71.23	gnl|BL_ORD_ID|910|hsp_num:0	870		
BGC0000257.1|Prodigiosin_6 # 4184 # 6949 # -1 # ID=1_6;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.777	BGC0000257.1|Prodigiosin_6 	4184	6949	-	Loose	300	27.335	AAC(3)-IIb	43.24	3002534	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	TTGCGCCGTGACGAGCCGGACCCGCCCCCGCCACCGGAACCCGTCGCCATCGTGGGAATCGCGGCACTCTATCCGCGCGCGCAAGGAGTGGACCGGTACTGGCGATTCCTGACCGAATTCCTGCCGGAATCCGGCGCACCGGCGCCGGAGCACCGCTCGCTGGCCGATATCGCCGACCACGAGGTCGATGTGGCCGCCTTCGGCATTCCGCCGGCCCAGGCGGGGTCGATGGCCCGCATGCAGCTGCTGATGCTGGAGGCCGCCCGGCAGTGCCTCGCCGACGCGGGCCACCCCGGGCGCCCGCTGCCCGCCGACCGCACCGACGTGCTCACCGGTACCTGCTTCGGGCTCGACCGCCAGTACGCCAACGCGCTGCGGGTGGAGGGCAGCAGGTACGCCCGCGAGCTGGAGCGGGCCGCCTCGTCGGAGGAGGCCGGCGCCCAGCTGCGGCAGCTCCTGCTGGACCGGCTGGGCGGGTCCCCGCACGACCGGGTCGGCGAGATGGCCAGCACCATCCCGGCCCGGATCGCCACGGCCTTCAAGCTGCGTGGCCGGGCGCTGGCGCTGGAGTCCGCCGACGCGACCTCCGTACTGGGCATCGCGCAGGCGGTGCACAGCCTGCGGGACGGCTCGGCGGATGCCGCCCTGGTGCTGGCGGGGCAGCTGCGGGAGAACCCGCTGCTCCCCGCGGCCCTGGCCGCCAAGCAGGCGGCGGACGGCCGCAGCGGCGGGACACTCGGCGAGGGCGTCGGGGCCGTGCTGCTCAAGCGGCTGTCCTCGGCGGTGGCGGACGGCGACCGGGTGTACGCCACTCTCAGGGCGTGCGCCGTCCGGCACGCGCCGCGCCCGGGCGTCTTCCGCCACCCGGCGGCGCCGGGGGCGCGCCGGGCCACGGCGCGCGCGGCCTGTGCGGCGGCCGGGGTGCCGGACGCCTCGGTCCGCTACGTGGAGTGCACCGGCTCCGGCGCGCCGCACGAGACGGCGGCCGAGCAGGAGGCGTTCGGCGGCACGGCCACCGTCACGCTGGGCAGCGTGCGGGACCGGCTGGGCCACACCTTCGCCAACGCCGGGATGGCCGCGCTCACCAAGGTGGCGCTGGCACTGCACCACCGCAGCATCCCGGCGCCCGGCACGGCCCGGGACTGGCCCGCGGACCCCGGCGGCGCGCCGCGCCGCGCCGCCGTCAGCGGCGCCTCACTGACCGGGACGCTCAGCCATCTGCTGCTGGAGGAGTACGTGCCGCCCGCCGCCCCGGCGGCGGCCACGGGCCGGGCCCCCCGCTCGCGCACCGCGGCGCGGACGGAGGCCGCCGCCGAGCCGATCGCGGTGATCAGCTACGGCGCCCGTTTCTCCGGCGCGCCCGACGCGGACAGCTGCTGGCAGGCGTACCTCTCCGGCCGCGACCGGATCGGGCCGCTGCCGCCCGCCCTGCTCGACCGGGACCTGTACCACGCCCCCGGCGCGCTCAGCTTCAGCCACGCGTACACCGACCACGGCTCCCCCGTCACCGTCCCCGACCGCCCGCCGCCGGGCCTGTCCCTCACCCCGGAGCGGTACGCCGCGCTGGACCCGGCGCAGCGCGTCGGGCTGGCCGTGGCCGCCGAGGTGCTGTCCGGGCACCGGCCCGGCGCGCCCGGCCTGACCGGGGCCGGGCTGATCGCCGTCGGCTCCAGCCTCGGCCTCGGCCGCGACCGTCTCGCGGGCGCCCGGCACGGGCTGCGCGCCCTGGAACCGGAGTTCGCCCGGCTGCCCGCGCTCGCCCGGATGTCCGCCGCCGACCGGGAGAAGCTGCTCGACCTGGTGCGCGAGCGGTACGCGGCGGCCACCGCCCAGGACGGCGCGGGCGGCGCGGGCGGCACGGACGGCGGGCACAGCCCGGACGACGCGGCCGGCCCCGGCGGGGGCACCCTGGACGGCTGGCTGGCCAGCGGCACGGCGGCGCTCATCGCCGGCGAGTACGGCCTGTCCGCCACCCCCGTCGCCGTCGAGGCCGCCTGTGCGTCCTCGCTGGCGGCCCTCGACCTGGCCGCCGGGCAGCTGCGGGCCGGCTCCGTCGACTACGCCCTCGCGGGCGGCGTCGAACTGCCCTGCAACGCCAGGGACATGATCCTGTGCTGCTCGCTCGGCCTGCTGTCCCGCACCCGGATCACCCCGTTCGACTCCGCCGCCGACGGGTTCACCCCCGGCGACGGCTGCGCCCTGTTCCTGCTCAAGCGCTACGCGGACGCCCGCAGGGACGGCGACCCCATCCTGGGCGTGCTGCGCGGCATCGGCGCGTCCAACGACGCCAAGTCCCTGATCGCACCGGACACCGACGGCCAGGCAAGGGCGATCCGGCGCGCCTTCGCCCAGGCAGGGGCGGACTTCCCGCCCTCCTCGGTGGACTACCTGGAGGCGCACGGCACCGGCACGCAGGTCGGGGACCGGGTGGAGATCGCCGCCGCCGCCCGGGTGTACGCCGCGCCGGAGCGGACCCGTCCGCTGGAGGTCGGCTCGGCCAAGTCCTTCTTCGGGCACACCTTCGCGGCGGCGGGCAGCGCGGGGCTGCTGCGGGTGCTGCTGGCCCTGAAGGCCGGGACGCTGCCCCCGAACACCAATCTGCACCGCCTCAACCCCGCGCTGGGCCTGGCCGCCGTGCCGGCCGCGGTGTCCACACAGGCGGCCCCCTGGGAGCCGGTGGCCGGGCGCCCCCGCCGGGCGGCGGTCAGCTCCTTCGGTACCGGCGGCATCAACTACCACCTGCTCGTCGAGGAAGGTCCGCGATGA	MRRDEPDPPPPPEPVAIVGIAALYPRAQGVDRYWRFLTEFLPESGAPAPEHRSLADIADHEVDVAAFGIPPAQAGSMARMQLLMLEAARQCLADAGHPGRPLPADRTDVLTGTCFGLDRQYANALRVEGSRYARELERAASSEEAGAQLRQLLLDRLGGSPHDRVGEMASTIPARIATAFKLRGRALALESADATSVLGIAQAVHSLRDGSADAALVLAGQLRENPLLPAALAAKQAADGRSGGTLGEGVGAVLLKRLSSAVADGDRVYATLRACAVRHAPRPGVFRHPAAPGARRATARAACAAAGVPDASVRYVECTGSGAPHETAAEQEAFGGTATVTLGSVRDRLGHTFANAGMAALTKVALALHHRSIPAPGTARDWPADPGGAPRRAAVSGASLTGTLSHLLLEEYVPPAAPAAATGRAPRSRTAARTEAAAEPIAVISYGARFSGAPDADSCWQAYLSGRDRIGPLPPALLDRDLYHAPGALSFSHAYTDHGSPVTVPDRPPPGLSLTPERYAALDPAQRVGLAVAAEVLSGHRPGAPGLTGAGLIAVGSSLGLGRDRLAGARHGLRALEPEFARLPALARMSAADREKLLDLVRERYAAATAQDGAGGAGGTDGGHSPDDAAGPGGGTLDGWLASGTAALIAGEYGLSATPVAVEAACASSLAALDLAAGQLRAGSVDYALAGGVELPCNARDMILCCSLGLLSRTRITPFDSAADGFTPGDGCALFLLKRYADARRDGDPILGVLRGIGASNDAKSLIAPDTDGQARAIRRAFAQAGADFPPSSVDYLEAHGTGTQVGDRVEIAAAARVYAAPERTRPLEVGSAKSFFGHTFAAAGSAGLLRVLLALKAGTLPPNTNLHRLNPALGLAAVPAAVSTQAAPWEPVAGRPRRAAVSSFGTGGINYHLLVEEGPR	MNTIESITADLHGLGVRPGDLIMVHASLKAVGPVEGGAASVVSALRAAVGSAGTLMGYASWDRSPYEETLNGARMDEELRRRWPPFDLATSGTYPGFGLLNRFLLEAPDARRSAHPDASMVAVGPLAATLTEPHRLGQALGEGSPLERFVGHGGKVLLLGAPLDSVTVLHYAEAIAPIPNKRRVTYEMPMLGPDGRVRWELAEDFDSNGILDCFAVDGKPDAVETIAKAYVELGRHREGIVGRAPSYLFEAQDIVSFGVTYLEQHFGAP	342.38	gnl|BL_ORD_ID|870|hsp_num:0	925		
BGC0000257.1|Prodigiosin_7 # 7132 # 7692 # -1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.736	BGC0000257.1|Prodigiosin_7 	7132	7692	-	Loose	500	23.483	sul1	30.77	3000410	protein homolog model	n/a	n/a	sulfonamide antibiotic	antibiotic target replacement	sulfonamide resistant sul	GTGCTGCGCGCGGTACGCAACGGCTACCTGCTGGACGTCCCGCCCGACTGCGTCGACGGCAACCGCTTCCTGGACCTCGCGGCCCAGGGCGCCGCCGAGCTGTACACCAGGCCGGAGCGGGCGCTCGAACTGCTTCAGGCCGCGCTGCGCCTGTGGCGCGGCCCCGCCCTGCTCGACGCGGGCGACGGGCTGCGCTGCCGGAGCGCCGCCGCCCTGTTCGAGGAGCGCCGGCTCACCGTCTGGGAGGACCTGATAAGCGCACGGCTGGCGCTGGGGGACGAGTCGCGCGCCATCGCGGAGCTGCGCCAGCTGGTGGCGCAGCACCCGCTGCGCGAGCGGTTCTGCGAGCTGCTCATGCTGGCGCTCTACCGGTCGGGCCGGCAGGGCGATGCGCTGGAGCTGTTCCGCACCACCCATCAGCGCCTGGACGAAGAGCTGGGCGTACAGCCCGGAGTGGAGCTGCAACGGCGGCACGCCGAGATCCTGTCCCAGAATCCCGCGCTCTCGCTGCCCTCGGCACTGCTCCCCGACCATCCGCGTCCGGCCACGACGCGGTGCTGA	MLRAVRNGYLLDVPPDCVDGNRFLDLAAQGAAELYTRPERALELLQAALRLWRGPALLDAGDGLRCRSAAALFEERRLTVWEDLISARLALGDESRAIAELRQLVAQHPLRERFCELLMLALYRSGRQGDALELFRTTHQRLDEELGVQPGVELQRRHAEILSQNPALSLPSALLPDHPRPATTRC	MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA	66.67	gnl|BL_ORD_ID|1005|hsp_num:0	1070		
BGC0000257.1|Prodigiosin_9 # 8450 # 10783 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.725	BGC0000257.1|Prodigiosin_9 	8450	10783	-	Loose	1280	40.817	macB	24.0	3000535	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGCTCCTCAAGACCCGGCGCGACGTGCGCCGGCGTCTGCCGCAGTTCGCGGCGATCGCGGTCACCGTGATGGTCGGGGTGCTGCTGTTCGTCGCGAGCTACGACGCCTACCGGAACCTCGCCGCCTCGTACGACGAGACGTACTCCCGGCTGCACTTCGCGGACCTCACCGCGTCCGGCGGCGACCCGGAGAAGGTCGCCGCGGCCGTCCGCGGCGAGCGCGGCGTCACCGGTGTCACCGCACGGCCGCAGGCCGACCTGGCGATGGAGATCAGCGACGACAAGCTGGCCGGACGGCTGATCGGGATGCCCGGTGAGGGGGAGCCCGAGGTCAACCGGGTGGATGTGACCGAGGGCGAGGGGCTCAGCCCCGGCGCCCCCGGCGGCGTGCTCGTCGAGCGGCACGCCGCGGACACCTGGGACCTGTCGCCGGGCGACAAGCTCAAGGTGTTCGACGGCTCCGCCTGGCAGTCCGTCACGGTGCGCGGGGTGGCCGTCTCCGCCGAGTACCTGTGGCCCGCCCCCAGCCGCCAGGAGGTGCTGGGCGATCCGCACTCCTTCGCGGTGGTGTTCGCCACCGAGGAGACCGCGCGCGCACTCGCCGGTGACCGGGCCACGCCGCAGACGCTGGTGCGGCTGTCGGACGACGCCTCGGCGGGCGCGGTGACCGAGCGGCTGCGCGAGGCGGGCGCGCTGGATGTGCTCAAGAAGAAGGACCAGCCGTCCAACGCCACCCTGCACGAGGACCTGAAGGGCTTCGAACAGCTCGCGCTGGGCTTCCCCGTGCTGTTCCTGGCCGCCGCAGCCATCGCAGCGTATGTGCTGATCACCCGCCTGGTGCTGTCCGAGCGGAAGGTCATCGCCACCTTCCTGGCCGCCGGTGCCCCGCGCGGTGCCATCGTCCGGCACTACCTGGGCCACGGCATCCTGGCCGGCACGGCCGGGGCCGTCATCGGCCTGGTCCTCGGCACGGTGGCCACCTCCGCGGTCACCAGGGCCTACACGAACGGCCTGGACATCCCGGACACCGTGGTGGAGCACCGGCCGCTGGTGGCCGTGACGGGCCTGCTCTTCGGCCTCGTCGTCGGCCTCGCGGGCGGTTACGCCCCGGCGCGCTCGGCGTCCAGGGCGGCGCCCGCCGAGGCGATGCGCGGCGACGTGGGCACCCTGAAGCCGCCGGGCCCGTGGAGCCGCGCGGTGGCCAGGGCCCGGCGGCTGCCGGTCACCACCCGGATGGCGCTGCGCGAACTGACCCGCAGCCGCCGCCGTACCGCGGCCACCATGACGGGCACGGTGCTGGCGCTGATCCTGGTGCTCGCCTCCGTCGGCATGATCACCAGCATGACGGCGCTGATGGACACCCAGTTCGACAAGGTCCAGAAGCAGGACGCCACGGTGACGGCCGATCCCCGCGCCGGTGACCTGGCCGAACAGATCGGCGCGGTCCGCGATGTCGGTGAGGTCGAGCGGATCACCCAGGTCCCGGCGACGGTGACGGCCGAGGGCTCCTCGTACTCCACCTCGCTCACCGGTTTCCGCCCCGGCACCAGCATGCACGGCTTCCGCACGGACGACGGCGGCACCCGGAAGCTGCCGGAGGACGGCATCCTGGCCGGCAAGGCCCTCACCGACAAGCTGGATGTCGCCGTCGGCGACTCGGTCACCGTGCACACGCGCGACGGCAAGGAGCGGAAGGTACGGCTGGCCGGGCTGGTGGAGGAGCCGCTGGGCACCGCCCTGTACGGCACCCGGGACACCGTCCCGGAGATCTCCGGCATCGACGGCAACGCCTACCAGCTGCGTTTCGACGGCGACCTGGGTACCGACGCCCGGGACACGGCGCGTTCGGCGGTGACCGGCATCGAGGGCGTGGTGGCGTACACGGACGAACAGGCGCTGCGCCGCCAGCTGGACAAGTTCCTCGCGCTGTTCTGGATCTTCGCCGGGGTGATGCTGGTGCTCGGCGGCGTGCTCGCGCTGACCGTGATCTACGTGACGATGACCGTCAACGTCGCCGAACGCAGCGGCGAGCTGGCCACCCTGCGGGCGGCCGGGGTCTCGCTGCGCCGGGTCGCCGGCGTGCTGGCCACGGAGAATCTCACGGCGACGCTCATCGCGGTGCCGATCGGTCTGGCCCTCGGCGCGGTCACGGCGTACGAATCGCTGCGCGCCTTCGACAGCGACATGTTCACCATCGAGCTCTCGCTCGGCTGGCCGGTGCTGCTGGCCGCGACGCTGGCGGTGCTGCTGGCCTCGCTGCTCTCCCAGGTGCCGGCCGTGCGTATGGTGCGCAGGCTGGACATCGCCAGGGTGGTGAGGGAACGGGCGCAATAA	MLLKTRRDVRRRLPQFAAIAVTVMVGVLLFVASYDAYRNLAASYDETYSRLHFADLTASGGDPEKVAAAVRGERGVTGVTARPQADLAMEISDDKLAGRLIGMPGEGEPEVNRVDVTEGEGLSPGAPGGVLVERHAADTWDLSPGDKLKVFDGSAWQSVTVRGVAVSAEYLWPAPSRQEVLGDPHSFAVVFATEETARALAGDRATPQTLVRLSDDASAGAVTERLREAGALDVLKKKDQPSNATLHEDLKGFEQLALGFPVLFLAAAAIAAYVLITRLVLSERKVIATFLAAGAPRGAIVRHYLGHGILAGTAGAVIGLVLGTVATSAVTRAYTNGLDIPDTVVEHRPLVAVTGLLFGLVVGLAGGYAPARSASRAAPAEAMRGDVGTLKPPGPWSRAVARARRLPVTTRMALRELTRSRRRTAATMTGTVLALILVLASVGMITSMTALMDTQFDKVQKQDATVTADPRAGDLAEQIGAVRDVGEVERITQVPATVTAEGSSYSTSLTGFRPGTSMHGFRTDDGGTRKLPEDGILAGKALTDKLDVAVGDSVTVHTRDGKERKVRLAGLVEEPLGTALYGTRDTVPEISGIDGNAYQLRFDGDLGTDARDTARSAVTGIEGVVAYTDEQALRRQLDKFLALFWIFAGVMLVLGGVLALTVIYVTMTVNVAERSGELATLRAAGVSLRRVAGVLATENLTATLIAVPIGLALGAVTAYESLRAFDSDMFTIELSLGWPVLLAATLAVLLASLLSQVPAVRMVRRLDIARVVRERAQ	MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAGSGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKERSARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGKNVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQEKASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILEDISSMGTNTISIFPGRGFGDRRSGKIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNTDLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTILFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTRVAEKGLAELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNHFVTDFPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD	120.65	gnl|BL_ORD_ID|459|hsp_num:0	487		
BGC0000257.1|Prodigiosin_10 # 10800 # 11567 # -1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=ACC;rbs_spacer=15bp;gc_cont=0.710	BGC0000257.1|Prodigiosin_10 	10800	11567	-	Loose	1280	184.496	macB	39.0	3000535	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGCGCCCGGCACAGGAAGGCGATCCCCCGAGGAGGGACGGCATGACAGAGGCGAAAGCGCCCCGCGGCGGAGTCCGGCTACGCGGTGTCACGAAGAGATACGGCCAGGGTGAGGCCCAGCTCAAGGCGCTGGACGGCGTGGACCTGGACATCGAGCCGGGCGAACTGGTGGTCGTGCTCGGGCCCAGCGGCTCCGGCAAGACCACGCTGCTCAATGTGCTCGGCGGCATCGAGCCTGCCGACGAGGGCGAACTGACCGTGGCCGGCGTGGAGCTGACCGGGCGCTCCCCCAAGGACCTGGTGAGCTTCCGGCGGGACCGGGTCGGCTTCGTCTTCCAGTTCTTCAACCTGGTGCCCACGCTCACCGCCCGGGAGAACGTCGAGGCGATGGTGGAGCTGACCGGCCGCGGCGACCGCACGCAGGTGCCCGAACTGCTCGGCTCGGTCAACCTCACCGACCGGATGGACCACTTCCCGGCCCAGCTGTCCGGCGGCCAGCAGCAGCGGGTGTCGATCGCCCGTGCCCTGGCCACCGACCCGGACCTGCTGCTCGCCGACGAACCGACCGGTGCCCTGGACGTGGCCACCGGCAAGTCCGTGCTCCGGCTGCTCCAGGAGACCAACCGGCAGGGCCGCAGCGTGCTGATGGTCACGCACAACGCGTCGGTGGCCTCCATCGCGCACCGCGTGGTGACGATGCGGGACGGCAAGGTCGAGACCGTCGAGCAGAACGCCGCCCCGGCCGATGCCGTCACCGTGAGCTGGTGA	MRPAQEGDPPRRDGMTEAKAPRGGVRLRGVTKRYGQGEAQLKALDGVDLDIEPGELVVVLGPSGSGKTTLLNVLGGIEPADEGELTVAGVELTGRSPKDLVSFRRDRVGFVFQFFNLVPTLTARENVEAMVELTGRGDRTQVPELLGSVNLTDRMDHFPAQLSGGQQQRVSIARALATDPDLLLADEPTGALDVATGKSVLRLLQETNRQGRSVLMVTHNASVASIAHRVVTMRDGKVETVEQNAAPADAVTVSW	MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAGSGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKERSARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGKNVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQEKASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILEDISSMGTNTISIFPGRGFGDRRSGKIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNTDLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTILFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTRVAEKGLAELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNHFVTDFPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD	39.60	gnl|BL_ORD_ID|459|hsp_num:0	487		
BGC0000257.1|Prodigiosin_11 # 11617 # 12339 # -1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.747	BGC0000257.1|Prodigiosin_11 	11617	12339	-	Loose	375	35.8094	Escherichia coli acrR with mutation conferring multidrug antibiotic resistance	29.31	3003807	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAACGTCAACCCAGGGGCATACCGGAGCCGAGCGGGGAGTGATATGAGTCCGACATCCGCCGAACGCGGTCAGGAGAGCCGGGCGCGGCTGCTCGCCGCGGCGGCCGAGCTGATCGTGGCGGACGGCTGGGGCTCGGTGACCACACGCAAGGTCGCCGACCTGGCCGGCCTGCCGCCCGGCCTGGTCCACTACCACTTCCGTACGGTGACGGACCTACAGATCGACGCCGCGCTGGACGCCGCCCGGCGCGAGGTCGACGCGGCGACGGCGGCGCTGGTCTCGGCCGCCGATCCCGTGGCGGGGATGGCCGAGGTGCTGGATGAGCTGGCCGCCTACGCGGACAACGATCCGGCGACGATTCTCTTCAGCGAGATGCTGCTGGCCGCGACCCGGCACAAGCGGCTCCGCGAGGAGCTGTCGGTCCTGCTGGGCAACTGGCGGTCGACCATGGCCGACTGGCTGCGGTCGCACGGCGGCCCGGCGGACGCCGAGGCGACGGTACTGCTGCTCGGCGCGGCGCTGGACGGCCTGGTGCTGCACCGCATGGTCGACCCGGGGCAGACCCGGGTCTCGGTGGCAGGGCCGCTGCGCCGGCTGGCCGGCCTGCCGCCGCACCAGGGCGCCGGCGCGCAGGGCAGACCCGCAGCGCGGAGCGCGGCACCGCACGGCGCTGCCGGGACGACGACGGACGGACCCTCGGGCGACGGGTCCGTCAGCTGA	VNVNPGAYRSRAGSDMSPTSAERGQESRARLLAAAAELIVADGWGSVTTRKVADLAGLPPGLVHYHFRTVTDLQIDAALDAARREVDAATAALVSAADPVAGMAEVLDELAAYADNDPATILFSEMLLAATRHKRLREELSVLLGNWRSTMADWLRSHGGPADAEATVLLLGAALDGLVLHRMVDPGQTRVSVAGPLRRLAGLPPHQGAGAQGRPAARSAAPHGAAGTTTDGPSGDGSVS	MARKTKQEAQETRQHILDVALRLFSQQGVSSTSLGEIAKAAGVTRGAIYWHFKDKSDLFSEIWELSESNIGELELEYQAKFPGDPLSVLREILIHVLESTVTEERRRLLMEIIFHKCEFVGEMAVVQQAQRNLCLESYDRIEQTLKHCIEAKMLPADLMTRRAAIIMRGYISGLMENWLFAPQSFDLKKEARDYVAILLEMYLLCPTLRNPATNE	111.63	gnl|BL_ORD_ID|2147|hsp_num:0	2306		
BGC0000257.1|Prodigiosin_12 # 13296 # 15173 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.761	BGC0000257.1|Prodigiosin_12 	13296	15173	+	Loose	750	28.8758	patB	29.79	3000025	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGACCGCCGACGGCGCACAGCTCATCGGACTGCCATCGGACCTGCCTGCCGGGCAGGCGGACCGCCCGGCGCTGCTGGGCGAACGGACCGTCACCTACGGCGAGCTGGCGGCGGACGTGACCGCCACCGCCGCCGCACTGCGCGCGCTCGGGGCCCGCCCCGGCGACCGGGCCGCGATCTGGATGGACAAGCAGCCGCGCTACGCCGAGGCGATTCTCGCCGCGCTGCGCGCAGGCTGTGCGTACGTGCCGCTGGACGGCGGCCAGCCGGCGGCCAGGGCGGCGACGATCCTCGCCGACGCCTCGCCCGTTGTGCTGTTCACCGACGCGCGGCACCTGGCGGCACTCGACGGGCACACCCTGCCGGCGTCGGTGCGCGCGGTGGTGGTGACCGGCGCACCCCGTGACAGCAGCGGGTACGGCGCCCCGGACGGCGCCGAGGTGTGCGCCTGGGCGGACTTCGCCGCCCGCGCGCCGGGCGCCACGGACGCCCCCGCGGCGCAGCCGGACGGTCCGGACGGTGACGCGCTCGCCGCGCTCCTCTACACCTCCGGCTCCACCGGCGTGCCCAAGGGCGTGAAGATCTCGCACCGCAACCTGGCGAACTTCACCGGCTGGGCCCGCACCGAGCTGGACGTGGGCCCGGACGACGTGTTCGCCAACCACGCCTCCTTCAACTTCGACCTGAGCACCTTCGACCTGTTCACCGCGCTCGGCGCCGGCGCGGCCGTCTGGATCATCGACGAGCCGCGGGCCCGTGATGCCTCCGAACTGGCCGCCGGCATCGTCCGGCACGGCGTCACCGTCTGGTACTCGGTGCCCTCCGTGCTCAATCTGCTCACCGTCTCCGGCGCGCTGACCCCGGAGCGGGCGGCCGGGCTGCGGTACGTGCTGTTCGCGGGCGAGGTGTACCCGATGCCGCAGCTGCGCGCCCTGGCCGCCCTGCTGCCCGAACACACCGTGCTGTACAACCTGTACGGCCCCACCGAGACCAACGTCTGCACGTTCCACCGGGTGGGCACCGCGGACCTGGCCCGCGACGAGCCGGCCCCCATCGGCCTGCCCATCAGCAACACCCGGGTCTCGGTGGTGGACGAGGCGGGCCGCGCGGTCACCGGGGCAGGCGCGGTCGGCGAACTCGTGGTGGAGGGCGACTGCGTGACCCCCGGTTACTGGGGCCGCGAGTCGGAACCGGCCGCCGCGGGGCACCGCGCCCGCCGGCACGCCACCGGCGACCTGGTCACCCGCGAGGACGGCAGGCTGGTCTACCGCGGCCGCATCGACCGGATGGTGAAGCTCTCCGGCTACCGGATCGAGCTCGGCGAGATCGAGGCCGCCGTGCTGCGGCACCCCGCGGTCGCGGACGCGGCGGTGGTCGTCGCGGACGCACCCGGCGGGCAGGCCGGGCAGGTGGGGCAGGCCGGGCAGCAGGGGAACCGGGAGACACAGCGGCGGCTCGCGCTGTACTACACGCTGCGCGAGGGCGCCGCGAAACCGACCCTGGTGCAGCTGAAGCAGCACTGCGCCCGGCACCTGCCCGGGTACATGCTGCCGCAGATGGCCACGGTGCTGGGACGCGCTGCCGCGCAACGCCAACGGCAAGACGGACTACGCCCGGCTCACGGAGGCCGGCGCAAGACCGGCCGCGCGCCCGCGCGCCCGTACGCAGCGCACCGGCGGCGGTACCGCGGAGGCGGCGCCGACGGCGCCGGCCGCGGCGCCCGCGGGGACAGCAGCAGCGGACCGGACCCGCCCCCGCGTACCGGCGGAAGGGCCTGCGGCGCAAGGCGCGCCCGGGCGCGGCGGCGGAGACCCTGGTCGACGTGCTGCGCCGGCACGCGGGACACCGCCCGGACGCCCTCGCCTACCGCTTCCTGA	MTADGAQLIGLPSDLPAGQADRPALLGERTVTYGELAADVTATAAALRALGARPGDRAAIWMDKQPRYAEAILAALRAGCAYVPLDGGQPAARAATILADASPVVLFTDARHLAALDGHTLPASVRAVVVTGAPRDSSGYGAPDGAEVCAWADFAARAPGATDAPAAQPDGPDGDALAALLYTSGSTGVPKGVKISHRNLANFTGWARTELDVGPDDVFANHASFNFDLSTFDLFTALGAGAAVWIIDEPRARDASELAAGIVRHGVTVWYSVPSVLNLLTVSGALTPERAAGLRYVLFAGEVYPMPQLRALAALLPEHTVLYNLYGPTETNVCTFHRVGTADLARDEPAPIGLPISNTRVSVVDEAGRAVTGAGAVGELVVEGDCVTPGYWGRESEPAAAGHRARRHATGDLVTREDGRLVYRGRIDRMVKLSGYRIELGEIEAAVLRHPAVADAAVVVADAPGGQAGQVGQAGQQGNRETQRRLALYYTLREGAAKPTLVQLKQHCARHLPGYMLPQMATVLGRAAAQRQRQDGLRPAHGGRRKTGRAPARPYAAHRRRYRGGGADGAGRGARGDSSSGPDPPPRTGGRACGARRARARRRRPWSTCCAGTRDTARTPSPTAS	MKTVQFFWHYFKVYKFSFVVVILMIVLATFAQALFPVFSGQAVTQLANLVQAYQNGNPELVWQSLSGIMVNLGLLVLVLFISSVIYMCLMTRVIAESTNEMRKGLFGKLAQLTVSFFDRRQDGDILSHFTSDLDNILQAFNESLIQVMSNIVLYIGLILVMFSRNVTLALITIASTPLAFLMLIFIVKMARKYTNLQQKEVGKLNAYMDESISGQKAVIVQGIQEDMMAGFLEQNERVRKATFKGRMFSGILFPVMNGMSLINTAIVIFAGSAVLLNDKSIETSTALGLIVMFAQFSQQYYQPIIQVAASWGSLQLAFTGAERIQEMFDAEEEIRPEKAPTFTKLQESVEISHIVFSYLPDKPILKDVSISAPKGQMTAVVGPTGSGKTTIMNLINRFYDVDAGGIYFDGKDIRGYDLDSLRSKVGIVLQDSVLFSGTIRDNIRFGVPDASQEMVEVAAKATHIHDYIESLPDKYDTLIDDDQSIFSTGQKQLISIARTLMTDPEVLILDEATSNVDTVTESKIQHAMEVVVAGRTSFVIAHRLKTILNADQIIVLKDGEVIERGNHHELLKLGGFYSELYHNQFVFE	106.29	gnl|BL_ORD_ID|1957|hsp_num:0	2112		
BGC0000257.1|Prodigiosin_14 # 22486 # 23610 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=ACC;rbs_spacer=13bp;gc_cont=0.743	BGC0000257.1|Prodigiosin_14 	22486	23610	+	Loose	1200	35.8094	arnA	26.29	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGACTGACAGCGTGACCGAAGCGACCGGGCCCGCCGCGGAGCCGGCCCCCGAGGTGCTGGTGCTGGGCGCCACCGGCTTCATCGGCGGCCATCTGACCAGGCGGCTGGCCGAGTCGGGGCGCCGGGTACGGGTGCTGGCCAGGCCGGGCAGCGACCGGAGCGGGCTGGAGGGGCTGCCGGTCGAGACCGTCACCGGCTCGCTCGACGACCTGGACAGCCTGCGCCGGGCCGCGCGCGGGGTGCGCCACGTGTACAACTGCGCCGGCCTGTCCGCCGACTGGGGCAGCTGGGACAGCTTCCGCAAGGTGAACGTGGACGGCGCCAGGAACGCCGTGCTGGCCTGCGAGCACGCGGGCACCGTCGAGCGGCTGCTGCACGTGAGCACCACCGATGTGTACGGCTACCCCGCACTGCCCTGCGACGAGAGCGCCGGCGTCCAGGACATCGGGCTGCCCTACAACCGCAGCAAGCTCCGCGGCGAGGCCGCCGTGCGCCAGGCGGCCAAGCGCGCCGGGCTGCCGTACACCATCGTCCGGCCGGTCTCGGTGTACGGGCCGCGGTCCAAGGACTTCGTCATCGAGATCGGCCAGCTGCTGGTGCGCAAGCAGATGGTGCACATCAGCGGCGGCGCCGCCCCGGCGGGCCTGCTGTACGTGACGAACGCCGCCGACGCCATGATCGCCGCCTGCGAGAGCGACCGCACCGCGGGCAAGGCGTACAACCTGCGCGACGAGGGGATGACCACCTGGCGCGAGTACGTGGACGCCCTCGCCGCCGGGCTGGGCGTGAAGTCGCCCTCGATGAGCCTTTCCAGGCCGGTCGCGATGACCGTCGCGCGGCTCTCCGAGGCGGTGTACGGGGCGCTGCGGCTCAGCTCCCGCCCGGTGCTCACCCGGCACGCCGTGAACCTGTTCGACCGCGACCAGTCCTACGGCATCGCGCGTGCCCAGGAGGACTTCGGCTTCACCAGCACCGTCGGCTTCGAGGAAGGCATGCGGCGCACCCTGGAGTGGCTGGACTCGCCCGAGGGGCGGGCCCAGGTCGTCCGGAAGGGCGCCGCCACCGCCGGGGCCGGCGCGCCGCAGCCCGCCGCGCCCGCCGGGCGCGCCGAGGAGGCCGCGTGA	MTDSVTEATGPAAEPAPEVLVLGATGFIGGHLTRRLAESGRRVRVLARPGSDRSGLEGLPVETVTGSLDDLDSLRRAARGVRHVYNCAGLSADWGSWDSFRKVNVDGARNAVLACEHAGTVERLLHVSTTDVYGYPALPCDESAGVQDIGLPYNRSKLRGEAAVRQAAKRAGLPYTIVRPVSVYGPRSKDFVIEIGQLLVRKQMVHISGGAAPAGLLYVTNAADAMIAACESDRTAGKAYNLRDEGMTTWREYVDALAAGLGVKSPSMSLSRPVAMTVARLSEAVYGALRLSSRPVLTRHAVNLFDRDQSYGIARAQEDFGFTSTVGFEEGMRRTLEWLDSPEGRAQVVRKGAATAGAGAPQPAAPAGRAEEAA	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	56.50	gnl|BL_ORD_ID|1549|hsp_num:0	1643		
BGC0000257.1|Prodigiosin_16 # 25045 # 26304 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.706	BGC0000257.1|Prodigiosin_16 	25045	26304	+	Loose	500	28.8758	chrB	36.96	3001302	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGCGCCTGGGCGAAGAAGTGGTGATGTGGCGCGACGCGCGCGGCAACGCCGTCGTGCAGGAGGCCCGCTGCCCGCACAAGGGCGCGAACCTCGGCGCGGGGCGGATCAACCAGAACGCGCTGGAGTGCCCGTACCACGGCTTCCGGTTCGGCGCGGGCGGCGACTGCGAAGCGGTGCCCTGCCTCGGCTCCGAGGCCCGTATCCCCAAGGGCCTGCGCATCCGCAACTACCCGGTGCGGGAAGAGCACGACATGGTCTGGATGTGGTGGGGGGAGGAGCGGGAGAGCTACCCCGAGATCGACATCCCGCCGGAGGTCACCCGCTGGAAAGGCGTGCACGTCACCGGCTCCTGGCAGCAGCCGGTGCACTACACGCGCTACATCGAGAGCATGCTGGAGTTCTACCACGCGCCCTTCGTGCACCGCGGCTCGTGGTTCAACTACCTGGACTACATGTTCCTCTACGGGACGCTCCGCAAGTTCGGCATGGACGGCCGCGCCCGCTACCTCGCCGCCTGCAAGGTCGTCGACCACGAGCTGGAGGTGGACGGCACCACGCTGCGGTCCTCCTTCAACCTCACCCGGGAGGACGACCCCGAGCGCGGCGAACCGTACAAGGTGGTCTTCGCGTTCCCCGGCATGGTCCACGTGATGAACCGCAAGTTCGACATCACCATGTGGCTCACGCCGATCGACGAGAAGAACACCCAGATCCTGTTCCGCTGGTACGAGGCGGAGAAGCTGGCGCCGTTCCTGCGCAGCAGGCTGCTGCGCGGCGCGGTGCCCGGCGGGGCCATGATGCTCCAGCGCTGGGTGCCGGAGCGGCAGGACATGCGCGTCATCCTCGGCCAGGAGCCGATGGCGAGCGAGCGCGGCGAGAACAAGTTCATCGCGGTGGACGAGATGAACGCCCGCTACCTGTCCCTGCGGCACAAGCTCATCCAGCACAACGGTGAGCTGCCGTCCGAAGGGGACCAGGACGCGGCAGGCAGGCCGCAGGAGGGCACCGCGGGCCGCGCACCCCGGCTGAACGGTTCGGGGGCGGTCATCGACCCGGCCGTCAAGGCCGCGATGACCAGGTCCGAGGCGAGGTCCGCGCAGAACGGCATGCCCGGCATGCCCGGCATGCCGAACGGCTCGGCCCGCCCCGGGCCCGCCCAGGGCAGCGGACGCGGCCCTGGCCGGGTGGTTGCCGCCGCGCGCGCCAAGGCGCGGATGGCCGCCGCCGAACGCGCCGAACGGGCGGCCGCCCGGCGCTGA	MRLGEEVVMWRDARGNAVVQEARCPHKGANLGAGRINQNALECPYHGFRFGAGGDCEAVPCLGSEARIPKGLRIRNYPVREEHDMVWMWWGEERESYPEIDIPPEVTRWKGVHVTGSWQQPVHYTRYIESMLEFYHAPFVHRGSWFNYLDYMFLYGTLRKFGMDGRARYLAACKVVDHELEVDGTTLRSSFNLTREDDPERGEPYKVVFAFPGMVHVMNRKFDITMWLTPIDEKNTQILFRWYEAEKLAPFLRSRLLRGAVPGGAMMLQRWVPERQDMRVILGQEPMASERGENKFIAVDEMNARYLSLRHKLIQHNGELPSEGDQDAAGRPQEGTAGRAPRLNGSGAVIDPAVKAAMTRSEARSAQNGMPGMPGMPNGSARPGPAQGSGRGPGRVVAAARAKARMAAAERAERAAARR	MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEARDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLLVVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLVGMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA	149.64	gnl|BL_ORD_ID|284|hsp_num:0	305		
BGC0000257.1|Prodigiosin_17 # 26541 # 27416 # 1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=ACC;rbs_spacer=13bp;gc_cont=0.767	BGC0000257.1|Prodigiosin_17 	26541	27416	+	Loose	1900	26.9498	mexN	30.0	3003705	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGATCCGGCCGGTGCGGCGGTGTGCGCACGTGGTACGGACGGACGGCGGTCCGCGCCACCTGCCCCGCCGCCCGCTGGTGCGCGAACAGGCCGGGCTGGTGTGGCTCTGGTGGGGCGCGGAGCGGGAGACGTACCCGGAGCCCTGGCTGCCTCCCGAGGTCGGCCGGCGCCCCGGCGTGCACGTGACCAGTTCCTGGGAGCGCCCGGTGTCCCCCCTCCGCTACCAGGCCGGCCTGCTCGACCTGTACCACGCGCCCGACCGGCACCACGGATGGTGGTACAGCCGGCTGGACTACGCCGTGCACGGCACACTGCGCGCCCTGTGGTTCGACGGGCGCGCCCGCTACCTGGCCGGCTGCGAACTGGCGGACCACCGCCTCGATGTGGACGGCGACACGGTGCGCTCCTCGTTCCGGCTCGCCCAGCGGGGCGGAGACCCGGCGCTCGACGAGCGGTTCACGCTGGTCATCACCCCCGGCATGGTGCATGTCCAGAGCCCGCGGCTGGACTTCACGGTGTGGCTGACGCCGGTCGACCACCGCCGTACCCTGCTGTTCTTCCGCTGGTACGAGGTCGCGGCGCTTGCACCGTACCTCAGGTTCCCGCTGCTGCGGGCGGCGCTGCCGGCGCTGATGATGCTCTGTCAGCGGCTGGTGCCGGCGCGGCAGATTGTCCGGATGGCCGCCGGCGCGCCGACGGGGGCCACCGCCGGCCCAGCGCCGGCCTGCCGGCGCCCGGCCGGCCGCACCGCCCCGGCACTCCCGTACGCGGCCTGGCGCGGACGCGCCGGCGCCCGCCGCCCGGCCGCCGGCAGCCCCGGCACCGCCCGCCTCCGGCAGGCCGCCGGCCTGCCGCAGGACAGCCCACGCCTGTGA	MIRPVRRCAHVVRTDGGPRHLPRRPLVREQAGLVWLWWGAERETYPEPWLPPEVGRRPGVHVTSSWERPVSPLRYQAGLLDLYHAPDRHHGWWYSRLDYAVHGTLRALWFDGRARYLAGCELADHRLDVDGDTVRSSFRLAQRGGDPALDERFTLVITPGMVHVQSPRLDFTVWLTPVDHRRTLLFFRWYEVAALAPYLRFPLLRAALPALMMLCQRLVPARQIVRMAAGAPTGATAGPAPACRRPAGRTAPALPYAAWRGRAGARRPAAGSPGTARLRQAAGLPQDSPRL	MTPRAGISGWCVRHPIATALLTLASLLLGLLAFLRLGVAPLPEADFPTIQINALLPGGSPETMASSVATPLEVQFSAIPGITEMTSSSALGTTTLTLQFSLDKSIDVAAQEVQAAINAAAGRLPVDMPNLPTWRKVNPADSPIMILRVNSEMMPLIELSDYAETILARQLSQVNGVGQIFVVGQQRPAIRIQAQPEKLAAYQLTLADLRQSLQSASVNLAKGALYGEGRVSTLAANDQLFNASDYDDLVVAYRQGAPVFLKDVARIVSAPEDDYVQAWPNGVPGVALVILRQPGANIVDTADAIQAALPRLREMLPATIEVDVLNDRTRTIRSSLHEVELTLLLTIGLVVLVMGLFLRQLSATLIVATVLAVSLSASFAAMYVLGFTLNNLTLVALIIAVGFIVDDAIVVVENIHRHLEAGASKVEAALKGAAEIGFTVISISFSLIAAFIPLLFMGGIVGRLFREFAVSVTVAILISVVASLTLAPMLASRFMPALRHAEAPRKGFAEWLTGGYERGLRWALGHQRLMLVGFAFTVLVAVAGYVGIPKGFFPLQDTAFVIGTSQAAEDISYDDMVAKHRQLAEIIASDPAVQSYNHAVGVTGGSQSLANGRFWIVLKDRGERDVSVGEFIDRLRPQLAKVPGIMLYLRAAQDINLSSGPSRTQYQYALRSSDSTQLALWAQRLTERLKQVPGLMDVSNDLQVGASVTALDIDRVAAARFGLSAEDVSQTLYDAFGQRQVGEYQTEVNQYKVVLELDARQRGRAESLDWFYLRSPLSGEMVPLSAIAKVAAPRSGPLQINHNGMFPAVNLSFNLAAGVSLGEAVQAVQRAQEEIGMPSTIIGVFQGAAQAFQSSLASQPLLILAALIAVYIILGVLYESFVHPLTILSTLPSAGIGAVFLLWAWGQDFSIMALIGIVLLIGIVKKNGILMVDFAIVAQREQGMSAEQAIYQACLTRFRPIMMTTLAALLGAIPLMIGFGTGSELRQPLGIAVVGGLLVSQVLTLFSTPVVYLALERLFHRRGTTTSDGGTAGATAT	28.09	gnl|BL_ORD_ID|2066|hsp_num:0	2217		
BGC0000257.1|Prodigiosin_18 # 27450 # 28550 # 1 # ID=1_18;partial=00;start_type=GTG;rbs_motif=ACC;rbs_spacer=14bp;gc_cont=0.701	BGC0000257.1|Prodigiosin_18 	27450	28550	+	Loose	500	28.4906	chrB	36.96	3001302	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	GTGGTATCCCGTCGCACGGTCCAAGGACGTCCGCAGGAACCGGCCGACCGGTGGCAAGCGGCCTGGCCAATAATGGTGATGTGCCGCGACGCGCGCGGCAACGCCGTCGTGCAGGAGGCCCGCTGCCCGCACAAGGGCGCGAACCTCGGCGCGGGGCGGATCAGCCGGAACGCGCTGGAATGCCCGTACCACGGCTTCCGGTTCGGCGCGGACGGGGACTGCGAAGCGGTGCCTTGCCTCGGCTCCGAGGCCCGTATCCCCAAGGGCCTGCGCATCCGCAACTACCCGGTGCGGGAAGAGAACGACCTGGTCTGGATGTGGTGGGGCGAGGAGCGGGAGAGCTACCCCGGGATCACCGCACCGTGGGAGGCCGCCCGCCACACCGGCGTGCACGCCACCGGCTCCTGGCAGCGCCCGCTGAACTACACGCGCTACATCGAGAGCATGCTGGAGTTCTACCACACGCCCTTCGTGCATAGCCGGGTCGTGGATTCAGCGGCCCCGACTACCTGTTCTACGGCACGCCGGGGAGGCTTTGGCGGGACGGGCGGCAGCCGCTATGTGGAGACCGCGAAGGTGGTCGACCACAAGGTGGAGACGGAAGGGACCACGCTCCGCTCCTCCTTCCGGCTGGTCCGCGAGGAGGACGAGGACGACCCCGCCAAGGGCGAACCGTTCACCATCGTGTTCACGTTCCCCGGCATGGTGCACGTCGTCAACGCGCGCTTCGACTTCACCATGTGGATCACGCCTGTCGACGAGGACCACACGCAGATCCTGTTCCGCTGGTACGAGGCCGCCTGGCTGCGGCCGTTCCTGCCCAGCAGGCTGCTGCGCGGCATCGCGCCGGGGCTGGGCACGGTGCTCCAGCGGATGGGCCCCGAGCCGCAGGACATGCGGGTCATCGCCGACATGCATCCGAAGGTCAGCCGGCGGGGCGCGTACAAGTTCGTCGCGGCCGACGAGATGAACGCCCGCTACCTGACGATCCGGCACCGGCTCCTGCACGGCGATCCGCCGCCGGAGGAGCACGCACCAGCCCAGGCCGGGCCCGGGCGGCAGGCCGGCCGGGCCGCACGAACCCACGTCCGTACCACCTAA	MVSRRTVQGRPQEPADRWQAAWPIMVMCRDARGNAVVQEARCPHKGANLGAGRISRNALECPYHGFRFGADGDCEAVPCLGSEARIPKGLRIRNYPVREENDLVWMWWGEERESYPGITAPWEAARHTGVHATGSWQRPLNYTRYIESMLEFYHTPFVHSRVVDSAAPTTCSTARRGGFGGTGGSRYVETAKVVDHKVETEGTTLRSSFRLVREEDEDDPAKGEPFTIVFTFPGMVHVVNARFDFTMWITPVDEDHTQILFRWYEAAWLRPFLPSRLLRGIAPGLGTVLQRMGPEPQDMRVIADMHPKVSRRGAYKFVAADEMNARYLTIRHRLLHGDPPPEEHAPAQAGPGRQAGRAARTHVRTT	MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEARDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLLVVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLVGMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA	130.71	gnl|BL_ORD_ID|284|hsp_num:0	305		
BGC0000257.1|Prodigiosin_19 # 28562 # 29650 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=ACC;rbs_spacer=14bp;gc_cont=0.716	BGC0000257.1|Prodigiosin_19 	28562	29650	+	Loose	550	32.7278	RlmA(II)	20.57	3001301	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGGACACAATGACTCCCCCCGACGGCGTGGCACGCCGCCGGGCGAAGCGGGTGGCCAACGCCGCCGGCGTCGCCAGGATCGCCGCCTCACCGCAGGTACCGCTGCTGCTCATGATGTCCCGGCGGCTCATCACGCCGGTCTACCGGGCCGCCTTCCTGGTGGCCGCGTCCAGCTCGGGGCTGCTGCGCCTGCTGGACCACCGCCCCTGCGACGCCGACTCGCTGGCCGGGAAGATGGAGATCAGGGACGTACGGCTGCTGCGGCTCTGGCTGGACGCCGGCGTCCGCCTCGGCGTGCTCGACCAGCGCTTCGACGGCTGCTACAAGCCGGGCAGCCGGGCCGCCAAGATGCTCGCCAAGGTACGGCACGACGCCGCCGCCGCGGCGCTCGAAGAGGTACTGCGCTACCACGTGCCGGCGCTGCTCAACGCTCCCTCGATGCTCAGGGAGGGGCGGCGGTTCTCGCTCGCCGACCAGGACGGCACGGTCATCGCCCGCTCCACCCAGGTGGTCACGCCGCTCGTGCACGAGGCGATCACGCACAGCGTGCCGCGCACCGGGCCGGTGCGGCTGCTGGAGATCGGCTGCGGCAGTGGAGTGCACGTACGGCACGCCGCCTCGCTGAACCCGCACCTCACGGCGCTGGCCGTGGACCTGCAGGCCGAGGTGGCCAAGCAGTGCGCCGAGAACATCGAGGACTGGGGTCTCGCGGACCGGGTCGAGGTCACCCAGGGCGATCTGCGCACGCTGGACCTGGAACCGCAGTTCGACCTGGTCACGATGCACAACAACATCTACTACTTCGCCGAGGACGAGCGGGTCGAGGCGCTGCGCCGGGCGCGGGAACTGCTCACCCCCGGCGGGCGGCTGCTGGTCACCACGGCCTGCCAGGGCGGACACCTGAGCCTGGACATGCTCAACCTGTGGCTGGAGTGCGCCGACTTCGGCGGGCCGCTGCCCAAGGAGCGGGAGCTGCTGGAGCAGCTGCGGGAGGCGGGGTTCGCCGACGCGAGTGCGGCGAAGATCGTGCCCGGCGAGGAGTTCCGTGCCTTCAGCGGCACGAACACGGACCTGGCGCAGCAGGACTGA	MDTMTPPDGVARRRAKRVANAAGVARIAASPQVPLLLMMSRRLITPVYRAAFLVAASSSGLLRLLDHRPCDADSLAGKMEIRDVRLLRLWLDAGVRLGVLDQRFDGCYKPGSRAAKMLAKVRHDAAAAALEEVLRYHVPALLNAPSMLREGRRFSLADQDGTVIARSTQVVTPLVHEAITHSVPRTGPVRLLEIGCGSGVHVRHAASLNPHLTALAVDLQAEVAKQCAENIEDWGLADRVEVTQGDLRTLDLEPQFDLVTMHNNIYYFAEDERVEALRRARELLTPGGRLLVTTACQGGHLSLDMLNLWLECADFGGPLPKERELLEQLREAGFADASAAKIVPGEEFRAFSGTNTDLAQQD	MNTNLKPKLQRFASATAFACPICQENLTLLETNFKCCNRHSFDLAKFGYVNLAPQIKQSANYNKENFQNRQQILEAGFYQAILDAVSDLLASSKTTTTILDIGCGEGFYSRKLQESHSEKTFYAFDISKDSVQIAAKSEPNWAVNWFVGDLARLPIKDANMDILLDIFSPANYGEFRRVLSKDGILIKVIPTENHLKEIRQRVQDQLTNKEYSNQDIKEHFQEHFTILSSQTASLTKTITAEQLQALLSMTPLLFHVDQSKIDWSQLTEITIEAEILVGKAF	128.37	gnl|BL_ORD_ID|2104|hsp_num:0	2274		
BGC0000257.1|Prodigiosin_20 # 30184 # 33294 # 1 # ID=1_20;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.722	BGC0000257.1|Prodigiosin_20 	30184	33294	+	Loose	1500	246.128	rphB	24.79	3003992	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	GTGGGACCGGTCGCGCGGAACGCGACGGCCTCGTCCGCGGTGGAGCCGCGGGAGGTGGCCGGGGCCGGGGATGATGCCGCCCGTCAGGGCGGGAAGGCGGCACGGTCGCGGGCGAAGAAGGCGGCGGGCGGTGACCCGTCGCGCAAGGCACCCGCCGCGAAGGCGGCCAGGCGGAAGACGGCCGCACCGTCCCGCCGTTCCCCCGCCGGCACCAGCCCGGCGGCGGAGCCGCCGGAGCCCGCCGCCGCTGCGGCGGGAACGCGCGCCCCCGCGCCGCCCGCGGATGGCCATGGTCCGCCCACCGGGCCCGGCACGGCGGCGGAGCCGCCCGCCCGCGCCCGGGCCGGCGCGTCCGCCGCGGCGCCGGAGGCGCCGTCGGCGGACGTCGCCGTGCTCGGCGCCGACGCCGCGGCGAAGCCGGAAACGCTGGGGGGCAAGGCCGCCCGTCTCGGCGAGATGATCGAAGCCGGCTTCCCCGTGCCGCCCGCCGTCTGCCTGACCACCGAGCTGTTCCACCGCTTCCTGCGCGAGACCGGCCTGGACAAGGAGATCGCGGGCGCGGACCGCCGCACCATCCGCGAGCTCGTCACCGGGCGGGAGATCCCCGCCGGTATCGCCTCGGTGATCACCGGCGCCTACCGCGGGCTCGGCCGCCCCTGCGTGGCCGTCCGGTCCTCGGCCGGCAGGAGGACTCGGCCGCGCAGTCGTTCGCCGGGCAGCACGACACGCTGCTCACTGACCGGCGACGACGCCGTGCTGGACGCCGTGCGTTCCTGCTGGGCCTCGCTGTGGTCGGACCGGGCCGGCGTGTACCACGACAGCGACGGCGACAACGACGGCGACAGCGACGGCGAAGGTGACGGCGACAGCACCGGCAGTACCGGCGCCGGTTCCATGGCCGTCGTCATCCAGGAGATGGTGCAGGCCGAGGTCAGCGGCGTGCTCTTCACCGTGGACCCGGTCAGCGGCCGGGAGCACCGCCTGGTCGTCGAGGCGTGCCGTGGCCTGGGCGAGGGCCTGGTCTCCGGGCGGGTGTCCAGCGACTTCTTCGCCCTGGACGACCGTACGTTCGAGGTGACCGAGCGGCTGATCCGGTACAAGGTGATGAAGTGCGCCCCGGTGGCGCCCGGTCAGGTCGGCATGGAGAAGGTGGACGCCGCCGCCCGCAACGCGCCCTGCCTCACGGGCGGCGAGCTGCGCGAGCTCGCCCAGCTCGCGGTGCGGGTCCGCGAGCACTACGGCGCCGAACAGGACATCGAATGGGCGCTGCGCGACGGCGAACTGCTGCTGTTGCAGACCCGCCCGATCACCACCGTGTCCGCCGGCGCGCCGCCGCCCGCCGCGGCGGGGGCGCGCAGCCCGTACGTCGAGGAGCAGCCGGAGGACATCCAGCAGGGCACCATGTGGTCCCGGATGGACATCGGCGAAATCTTCGTCGGCCTGATGACGCCGCTCGGCCTGTCCTGGGCCCGGCACCACCAGAGGTATGTGCACGGCCCGTGCGCTGCTTCGGTGGGCGCCAGGGACATGGGCGACCCCACCCGCTACATGGGCTACCTCCAGGGGCACGACAACCAGAACGTGTCGTACCACGCCCATCTGCTGGGGCAGTGCCCGCCCACCAAGAACCAGGAGCACTTCACCCGCCGTTTCGTCAGCGAGGAGGTGGACCTCGACCAGTACCGGAACCCGTTCGGCGCCTACCCGAAGGGCCTCAAGGGGCTGCGGTCGGCGAACTTCTGGGCCCGCACCACGGTCGCCGAGATGCGCGGCATGGCTGCGCGGGCACAGCACATGGCGACGGCCAGACTCTACGAGTTCGACCGGTCGCGGGCCCTTGACCTGTCGCTGTTCGACCGGCGCGAGCTGCATGTGGAGCTGGGCAGGTACCTGGTCAACTACCACGACATGCACGTCGGTTACATGCCGTACTACATCAACGCCTTCGGCGCGTACGGGCTGATGACCGAGCTGTGCGCCAAGTGGCTGGGCGACGCGGGCGCCAACCTCCAGAACCGGCTGAAGATGGACATGTCCAGCCTGCGCACCGTCGCCTCGGCCCAGGACATCTGGGAGCTGACCCAGGCCGCGCAGGCGCGTCCCGAGGTGCTGCGCCTCATCCGGGAGACGCCGCTGGAGAAGGTGGCGGACGCGCTGCTCGCCGATGTGGCGGGGCAGGAGTTCTGGGAGGGGCACCTGGAGCCGTTCCTGCGGGAGAACGGCGTGCGCGGCCGGCAGGAGATGGAGCTCACCAACCCGCGCTGGGTGGACGACCCGGCGTACGTGTTCCAGATGATCCGCCGGTACGCGGACGACAGCACCGCGGTCCAGGAGATCCTGGCCAGGGACCGCACCACGACCGGCGAGGACATCGAGGAGGTGCTGGCGCGGCTGCCGCGCATGAAGCGGGCGACGCTGCGCAAGGTGATCGGCCTGTACATCGGCAACAGCACGCTGCGCGAGGTCGCCAGGATGGCGATGGTCACCTCCATCTGGCAGGTGCGCAACATCGTGTACGAGGTGGCGCGCCGGCTGACCGAGGAGGGGCTGCTGCACTCGGTGGACGAGGTGGCGTACCTGGAGTTCCAGGACATCCAGCGCTACCTGGCCGGGGACGAGCCGGCCAGGGACATCTTCACCCGGGAGCGGATCGACGAGGCGCAGCGCCTGCACGACTACAACAACCGGCTGCCCGAGCCGCCGCTCACCTTCATGGGGGAGCACGACGCCACCCGCGCGTTGCAGGCGGCGGTGGCGGAGGCGGGCACGGGCCTGACGGGCCTCGGGTCGAGTCCGGGCCGGATCACCGGGCGGGCACGGATCATCGAGGACCTGGTGTGGCAGGCCGACGAGTTCCAGGTCGGCGAAATCCTGGTGACCCGGTACACGGACGCGTCGTGGACGCCGCTGTTCGCGATCGCCGGCGGGGTGGTCACGGACATCGGCTCGATGCTCTCGCACAGCTCGATCGTGTCGCGTGAGTTCAACGTGCCGTCCGTGGTCAACACCAAGCACGCCACGCAGCGGATCAACACCGGCGATCTGATCGTCGTCGACGGGGACAGCGGGGTCGTGGAGATCATCGAGCCCGCAGCCGGGGGTGGTGCGTGA	MGPVARNATASSAVEPREVAGAGDDAARQGGKAARSRAKKAAGGDPSRKAPAAKAARRKTAAPSRRSPAGTSPAAEPPEPAAAAAGTRAPAPPADGHGPPTGPGTAAEPPARARAGASAAAPEAPSADVAVLGADAAAKPETLGGKAARLGEMIEAGFPVPPAVCLTTELFHRFLRETGLDKEIAGADRRTIRELVTGREIPAGIASVITGAYRGLGRPCVAVRSSAGRRTRPRSRSPGSTTRCSLTGDDAVLDAVRSCWASLWSDRAGVYHDSDGDNDGDSDGEGDGDSTGSTGAGSMAVVIQEMVQAEVSGVLFTVDPVSGREHRLVVEACRGLGEGLVSGRVSSDFFALDDRTFEVTERLIRYKVMKCAPVAPGQVGMEKVDAAARNAPCLTGGELRELAQLAVRVREHYGAEQDIEWALRDGELLLLQTRPITTVSAGAPPPAAAGARSPYVEEQPEDIQQGTMWSRMDIGEIFVGLMTPLGLSWARHHQRYVHGPCAASVGARDMGDPTRYMGYLQGHDNQNVSYHAHLLGQCPPTKNQEHFTRRFVSEEVDLDQYRNPFGAYPKGLKGLRSANFWARTTVAEMRGMAARAQHMATARLYEFDRSRALDLSLFDRRELHVELGRYLVNYHDMHVGYMPYYINAFGAYGLMTELCAKWLGDAGANLQNRLKMDMSSLRTVASAQDIWELTQAAQARPEVLRLIRETPLEKVADALLADVAGQEFWEGHLEPFLRENGVRGRQEMELTNPRWVDDPAYVFQMIRRYADDSTAVQEILARDRTTTGEDIEEVLARLPRMKRATLRKVIGLYIGNSTLREVARMAMVTSIWQVRNIVYEVARRLTEEGLLHSVDEVAYLEFQDIQRYLAGDEPARDIFTRERIDEAQRLHDYNNRLPEPPLTFMGEHDATRALQAAVAEAGTGLTGLGSSPGRITGRARIIEDLVWQADEFQVGEILVTRYTDASWTPLFAIAGGVVTDIGSMLSHSSIVSREFNVPSVVNTKHATQRINTGDLIVVDGDSGVVEIIEPAAGGGA	MRSLVLDFQEMDKKQLGLVGGKGLHLGELSKIEGIRVPEGFCVTTIGYQRAIEQNETYQAMLNRLTMLSAEDRDQMVEISRKIRQTIMEVEIPSDVVTAVTRYLSRFGEEQAYAVRSSATAEDLPHASFAGQQDTYLNIIGVDAILQHISKCWASLFTDRAVIYRMQNGFDHRQVYLSVVVQRMVFPEASGILFTADPMTSNRKLLSIDAGFGLGEALVSGLVSADGYKVREGEIIEKRIAAKTLAIYGRKEGGTETKQIDPDQQKSQTLTDEQILQLARIGRQIEAHFGQPQDIEWCLAQDTFYIVQSRPITTLYPIPEANDQENHVYVSVGHQQMMTDPMKPLGLSFFLLTTPAPMRTAGGRLFVDTTAMLASPVSRENVLNTLGQSDPLIKDALMTILERGDFIKSLPIAENEQTPGKNNISSAGYQTPIDHDPTIVSDLMERTQSSIEVLKQNIQTKSGSDLFDFILEDIQELKKNLFDPQSSAVIMAAMNASTWINEKMNEWLGEKNAADTLSQSVPGNVTSEMGLALLDVADVIRPYPEIIDYLEQAKDDHFLDKLLTFDGGQQAQDAILDFLDKYGMRCAGEIDLTRTRWSEKPIALVPLILGNIKNFEPNASHRKFEQGRQEALKKEQELLDRLKQLPDGEGKAQETKRMIDLIRNFMGYREYPKYGMVNRYFIYKQALLKEAERLVQAGVIHHKEDIYYLTFEELDEVVRTNKLDNPGSMVEQQAKLAIRQMISKRKEEYNVFEKLTPPRVITSDGEIIAGEYKRENIPAEAIVGLPVSSGTVEGRARVILNMKDADLEEGDILVTAFTDPSWTPLFVSIKGLVTEVGGLMTHGAVIAREYGLPAVVGVENATKRIKDGQRIRVHGSEGYIEILS	117.19	gnl|BL_ORD_ID|2298|hsp_num:0	2528		
BGC0000257.1|Prodigiosin_21 # 33287 # 34543 # 1 # ID=1_21;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.674	BGC0000257.1|Prodigiosin_21 	33287	34543	+	Loose	300	28.4906	cpaA	32.43	3003994	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	cpa acetyltransferase	GTGCGTGAGGGGCGCCGCGGGCCCCCGCGCGGGCGCGGGCACCCCCGCGCCCCCGCACCCCAGGACCGGTACACCGTGCCGCACGCACAGCTGGACAGGAGTGACAGAGAAATGATCCCGAATCAGTGGTACGCCATCCTTCTGTCGGGGGATGTGAAGAAGAACAAACCGCACAAGACCCGGCGCATGGGCGAGAACCTCGTGGTGTGGCGGGACATCGAGGGGAAAGTGGTCTGCCAGCAGGCCAGGTGCCCGCACAAGGGCGCCAACCTCGCGGACGGCCGGGTCATGGGGAATTCCGTGGAATGCCCTTACCACGGTTTCCGGTTCGACCCCTCGGGGCAGTGCGTCGCGGTGCCCTGCCTGGGGACGGAGGCGCGTATTCCGCCCTCGATGCGGGTGAAGAGCTACCCCGTCCGCGAGCACCTCGGGCTCATCTGGATGTGGTGGGGCGAGGACCGCGAGGTACTGCCCGACCTCCCGATTCCGCAGGAAGTGGCGGAGAAGGAGAAGGAAGGCACATACGCGACGATGCGCTGGACCCGTCCGGTGCACTACACGCGTCATATCGAGAGCACGCTGGAGTTCTACCACATCACCTTCGTGCACCGGGGGCACTGGTTCAACTCCATCGACTACCTGTTCCTCTACGGCACCCCGGCCAAGCTGGGCCTGGACGGCCGCAAGCGCTACCTGGCGGCGACCAAGGTGGAGAACAACCACCTGGAGGTGGACGGCACCACCCTCCGCTACTCCTACGACCACCTGGAGGAGGGCACGAAGGCGAACTGCAACCACTACGACGTGATCTTCCAGTTCCCGCACATGACGCATGTGGCGAACAAGCAGTTCGAGGTCACCGCGTGGTTCGCGCCGATCGACGACCACAACACCGAGTTCATCCTGCGCTGGTACGAGTTCCCGCGGCTGCGGGGCATGCTGCGCGCCGAGCGGCTGCGGCGGCTGTTCCCTGCGGCCGGGCTGTACATGGAGAAGTGGATCCAGGACATGCAGGACGTCCGGGTGATCCAGGGCCAGCAGCCGCAGATCACGCAGCGCGGGGCGAGCAAGTTCGTGGCGGTGGACGAGCTGAACGCGAAGTACGTCTCGATGCGGGCGCAGCTCATCGCGGAGGCGAACGCCGGCACCGCGGGCGACGGCAAGGACAGCGCCGGGCGGGACGGCCGCGAACTGCGTGCCGCGGTGCCCGGGGGCACGGGCGCAAGCACCAACGGGCACACCCAACGGGCACCGTAA	MREGRRGPPRGRGHPRAPAPQDRYTVPHAQLDRSDREMIPNQWYAILLSGDVKKNKPHKTRRMGENLVVWRDIEGKVVCQQARCPHKGANLADGRVMGNSVECPYHGFRFDPSGQCVAVPCLGTEARIPPSMRVKSYPVREHLGLIWMWWGEDREVLPDLPIPQEVAEKEKEGTYATMRWTRPVHYTRHIESTLEFYHITFVHRGHWFNSIDYLFLYGTPAKLGLDGRKRYLAATKVENNHLEVDGTTLRYSYDHLEEGTKANCNHYDVIFQFPHMTHVANKQFEVTAWFAPIDDHNTEFILRWYEFPRLRGMLRAERLRRLFPAAGLYMEKWIQDMQDVRVIQGQQPQITQRGASKFVAVDELNAKYVSMRAQLIAEANAGTAGDGKDSAGRDGRELRAAVPGGTGASTNGHTQRAP	MPLRITAMTETYADQIMQWSYEPPYDFYNSEPDEEFRKELLECSYYAILDKEGQLFGFCCTGSSAQIPIAIPLGAYDEDLLDFGLGMKPESTGQCRGKEFLSFVLASIAEFHKRQSFRLTVAKFNERAIRLYTQLGFSEVATFDYGGTTFITMIKKPGSGL	259.63	gnl|BL_ORD_ID|2299|hsp_num:0	2529		
BGC0000257.1|Prodigiosin_22 # 35304 # 35555 # 1 # ID=1_22;partial=00;start_type=GTG;rbs_motif=ACC;rbs_spacer=13bp;gc_cont=0.746	BGC0000257.1|Prodigiosin_22 	35304	35555	+	Loose	300	25.0238	dfrA6	26.53	3004547	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	GTGAGGGTGGGCGCGACGATGAGCACGGCGTCGGGCCGCCGCTCGGCCGCCGAGCGGACGGCCTGCTGCCCCGAGGTCTCGGCGCTGACCTCCATGCCGCGCTGCTCCAGCAGCGCCCGCAGACCTGCGCTCATGATGGCGCGGTCACAGCACACCAGAACGCGGATGTTCGTCAAGGGACCAGGCCCCCTGCCGCGTTTTCCGTGGCCCGCAGGGCCGGCCGACGGCATCCCGGCGCCCGTCCCCCCGTAG	MRVGATMSTASGRRSAAERTACCPEVSALTSMPRCSSSARRPALMMARSQHTRTRMFVKGPGPLPRFPWPAGPADGIPAPVPP	MKISIMAAVSENGVIGSGLDIPWHVYGEQLLFKAMTYNHWLLVGRKTFDSMGKLPNRKYAVVTRTEMVSNDPDVVYFTSVESALAYLDHTTTHVFVSGGGEIYKALIEQADVIHLSVIHKHISGDVFFPSVPQSFKQTFEQSFSSNIDYTYQIWTKG	52.87	gnl|BL_ORD_ID|2758|hsp_num:0	3255		
BGC0000257.1|Prodigiosin_23 # 35587 # 35871 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.589	BGC0000257.1|Prodigiosin_23 	35587	35871	+	Loose	500	22.3274	OXA-349	45.0	3001536	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAGTACCGTGGTAGCAGAAATCGCACGTATGACTCCCCCGCGTCATCGTCCGTGCAGTCTCGGCATAGCCTCAAGCTACTCCACGCTAGCATGCGAAATGAAGATTGAGGAGAACGTCGGCAATTCAATAAACCGTGAACCGGGTGCCGTCTTACCTGCTGTCAAGCTGTTGTTCGGTGTCCGAAAACGAGTCAATGCGCAGGGTGCGTGCACGTTTTCGGGCGGCGCTGTGAGGGAACCGGCGCGCGCACCGGGGCGCGCGGGGTCAGAATATGCGCGGTGA	MSTVVAEIARMTPPRHRPCSLGIASSYSTLACEMKIEENVGNSINREPGAVLPAVKLLFGVRKRVNAQGACTFSGGAVREPARAPGRAGSEYAR	MYKKALIAATSILFLSSCSSNTVKQHQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGQTEEIYGNDLKRAPTAYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPDWEKDMTLGDAMKASAIPVYQELARRIGLDLMSKEVKRVGFGNASIGSKVDNFWLVGPLKITPQQETQFAYQLALKTLPFSQDVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWIVQPQGEIVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL	34.43	gnl|BL_ORD_ID|602|hsp_num:0	646		
BGC0000257.1|Prodigiosin_25 # 37214 # 38098 # -1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.767	BGC0000257.1|Prodigiosin_25 	37214	38098	-	Loose	1200	25.0238	otr(A)	37.84	3002891	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGTCGCTCGCTGAGCCGGTGGCGGCGCCCGCCGGAGCCGCGGCGGCGCCGGTGACCCCGGCGGTACAGGGCGCACCGCCGGGGCTCCCGCAGCACGCGGTGTTCGCCGGTGGACGCCTCTTCGATGCGGCCCGCCCGCTGCACACCGGGCGGGCGCCCGGCGCGCGCACCCTCTCGGTGGTGTCCATAGCGTGGCTGCGTGCCCAGCCGCCGTCCGTGCGGGCGGCGCTGGAGCGGCGTCACCTCAGCCCGGCGGAGGCGGAGTTCGCCGAGACGCTCCAGCTGCCCAAGCGGCGCCTTGAGTGGCTGGCCGGGAGGCTCGCGCTCAAGCACGGGGTGTGCTCGCACCGGAGGGTGCATGGAGCCGGGGGGGCGCCCGGCGGGCACGGCGCGCACGCCCGGACACCGCTCCCCCGGGACATACAGGTGAGCGCCGTGCGCGACGGGCTGCGCGCCGGCAAGCCCACCGTGAACGCGCCGGTGGAGGTGGGCCTGTCGCACTCGGCGGACTTCGCGGTCGCGGTGAGCGGGCAGGCCCCGGTCGGCGTCGACCTGGAGCACAGCCGGGACATGCCGCCGATGCTGGCGCGGCTGCTGGCCGGGGACGGTGACGCCGCCGCGCGCACGCCGGGCAGGCGGCGGCTGGCGGCGATGCCGCTGCCGCTGCGCTGGGCGTGCCGTGAGGCGGTGCTCAAGCACTTCGGGTTCGGGCTGCGGGTCGATCCGTGTGAGGTGGCGCTGACCGAGTGGGATGCGGACGGCGGGTTCCACTGGCGGTACGGGCCGCAGCTGCGCCGCCTGGTGAGCCCCGCGGACGCGCGGGGTCTCGGCAGCTGGGCGCGGGAGATCGACGGTTACTTTCTCGCTCTCGTGTGGAAGTGGTGA	MSLAEPVAAPAGAAAAPVTPAVQGAPPGLPQHAVFAGGRLFDAARPLHTGRAPGARTLSVVSIAWLRAQPPSVRAALERRHLSPAEAEFAETLQLPKRRLEWLAGRLALKHGVCSHRRVHGAGGAPGGHGAHARTPLPRDIQVSAVRDGLRAGKPTVNAPVEVGLSHSADFAVAVSGQAPVGVDLEHSRDMPPMLARLLAGDGDAAARTPGRRRLAAMPLPLRWACREAVLKHFGFGLRVDPCEVALTEWDADGGFHWRYGPQLRRLVSPADARGLGSWAREIDGYFLALVWKW	MNKLNLGILAHVDAGKTSLTERLLHRTGVIDEVGSVDAGTTTTDSMELERQRGITIRSAVATFVLDDLKVNLIDTPGHSDFISEVERALGVLDGAVLVVSAVEGVQPQTRILMRTLRRLGIPTLVFVNKIDRGGARPDGVLREIRDRLTPAAVALSAVADAGTPRARAIALGPDTDPDFAVRVGELLADHDDAFLTAYLDEEHVLTEKEYAEELAAQTARGLVHPVYFGSALTGEGLDHLVHGIRELLPSVHASQDAPLRATVFKVDRGARGEAVAYLRLVSGTLGTRDSVTLHRVDHTGRVTEHAGRITALRVFEHGSATSETRATAGDIAQAWGLKDVRVGDRAGHLDGPPPRNFFAPPSLETVIRPERPEEAGRLHAALRMLDEQDPSIDLRQDEENAAGAVVRLYGEVQKEILGSTLAESFGVRVRFDPTRTVCIEKPVGTGEALIELDTRTHNYFWGAPWVCASDRPSPARAITFRLAVELGSLPLAFHKAIEETVHTTLRHGLYGWQVTDCAVTLTRTGVRSPVSAADDFRKANARLVLMDALGRAGTEVHEPVSSFELEVPAARLSPVLAKLAELGATPGVPTAEGDVFRLEGTMPTSLVHDFNQRVPGLTQGEGVFLAEHRGYRPAVGQPPVRPRPEGPNPLNRDEYILHVLKRV	44.34	gnl|BL_ORD_ID|1221|hsp_num:0	1273		
BGC0000257.1|Prodigiosin_26 # 38085 # 38978 # -1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.699	BGC0000257.1|Prodigiosin_26 	38085	38978	-	Loose	350	25.0238	catB11	41.67	3004660	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGGCGTTCACCCTTCCGGCGACGGAGATCGAGGACCTGGAGGCACAGGTCCAGGCGGCGCTGCGGGCCGCCGACCACTCCGGGCTCACCGTGCTCGGGTACGGCGAGGTGTCCCTCGTGCTGGCGCTGGAGACCGGGGCAGGCAGCTTCGCCTGCAAGAGACTTCCCGTCTTCCCCGGTGCGGAGCAGCTGAAGACGTACGAGCGGTCGCTGGCCGAGTACATCCAGCGGCTGCGCGCCGCGGGCGTCACCGTCGCCGATTCCGACCTGTGGCACCGGCAGCTGCCCTCCGGCGGCACGGTGGCCTATGTGGTGCAGGAGGTGCTGCCCGCCAAGCGGCTGGTGTCGCAGCTGCTGCACAGCGAGGACGACGAGTGGGCGGAGGACTTCTTCACCCGGTTCCTGGACCGGGTGGAGGGTGCCGTGTCGCCGGTGCTCGGCCTGGACGCGCAGGCGTCCAACTGGGTGGATCTCGACGGCGAGCTGGTCTACCTGGACATCACCACGCCACTGATGCGGGATGCCCGCGGCCGTGAACGTCTCGACGTGCGGCTGTTCTACTCCTCGCTGCCCTGGGCGCTGCGCGATGTCACGCGGCTCACCATGACCGGTTCGATCCTGAACAAGTTCTACGAGCCGCGCGGCGTGGTGCTGGACTTCCTCGGCAACCTGCACAAGGAGCGGCTGAGCGCGCGGCTGCCCCGGTTCCTTGAGCAGGCCAATGCCCGGCTGCCGGGCAAGCCGATCACGGCGGACGAGGTGTCCGCGTACTACAAGGGCGACGCCCGCATGTGGGAGCTGCTCCAGCGGCTGCGCCGGGCCGACCGGCTCTGGCACCGGAAGATCCGGCGCCGGGTGTACCCGTTCCTGCTGCCGCCCGATGTCGCTCGCTGA	MAFTLPATEIEDLEAQVQAALRAADHSGLTVLGYGEVSLVLALETGAGSFACKRLPVFPGAEQLKTYERSLAEYIQRLRAAGVTVADSDLWHRQLPSGGTVAYVVQEVLPAKRLVSQLLHSEDDEWAEDFFTRFLDRVEGAVSPVLGLDAQASNWVDLDGELVYLDITTPLMRDARGRERLDVRLFYSSLPWALRDVTRLTMTGSILNKFYEPRGVVLDFLGNLHKERLSARLPRFLEQANARLPGKPITADEVSAYYKGDARMWELLQRLRRADRLWHRKIRRRVYPFLLPPDVAR	MKNYFESPFKGKPLVEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLLPDRDDVDKLIIGSFCSIGTGASFIMAGNQGHRYDWVTSFPFFYMNEEPAFSESVDAFQAAGNTVIGSDVWIGSEAMIMPGVKVGHGAVIGSRALVTKDIEPYTIVGGNPAKEIKKRFSEQEISMLLDMKWWDWPLEQIKEAMPLLCSSDIAGLYHFWQRSSA	141.43	gnl|BL_ORD_ID|2257|hsp_num:0	3360		
BGC0000257.1|Prodigiosin_27 # 39050 # 39169 # -1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.692	BGC0000257.1|Prodigiosin_27 	39050	39169	-	Loose	675	20.7866	emrA	34.62	3000027	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTCCTTCGCGGACCTCCGGATGGGCTCGCTCTCCGTGCGGGAGCTGCTCCTCGCCATCCAGACCGAATTCGGCGTACGGCGCGCGGCGGACCCGGGCGCGACATCCTGCCCTTCCTGA	MSFADLRMGSLSVRELLLAIQTEFGVRRAADPGATSCPS	MSANAETQTPQQPVKKSGKRKRLLLLLTLLFIIIAVAIGIYWFLVLRHFEETDDAYVAGNQIQIMSQVSGSVTKVWADNTDFVKEGDVLVTLDPTDARQAFEKAKTALASSVRQTHQLMINSKQLQANIEVQKIALAKAQSDYNRRVPLGNANLIGREELQHARDAVTSAQAQLDVAIQQYNANQAMILGTKLEDQPAVQQAATEVRNAWLALERTRIISPMTGYVSRRAVQPGAQISPTTPLMAVVPATNMWVDANFKETQIANMRIGQPVTITTDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIELDQKQLEQYPLRIGLSTLVSVNTTNRDGQVLANKVRSTPVAVSTAREISLAPVNKLIDDIVKANAG	10.00	gnl|BL_ORD_ID|1656|hsp_num:0	1757		
BGC0000257.1|Prodigiosin_29 # 41045 # 41323 # 1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.616	BGC0000257.1|Prodigiosin_29 	41045	41323	+	Loose	600	26.9498	Acinetobacter baumannii AmvA	34.38	3004577	protein homolog model	n/a	n/a	macrolide antibiotic; acridine dye	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACTCCTCAGAATCTCATCTTCGACTACATCGCCGATGTGTGGATGGACGGTGACGCGGAGGGCCTGGAGGACGAGACGCCCATCGCCGAGCTGAACATCATCGACTCGGCCGGGATCTACGACCTGGTGCACTACCTCCAGGGTGAATTCCGGATCACCGTTCCCTTGCAGGACATCTCCCTGAAGAACTTCCGTTCCGTCAGCACGATCACGGCGCTCGTCGACCGCTTGCAGAAGGCGGACCGGGCGGCGGAAGAAGTGGGAGGGGCCGCCTGA	MTPQNLIFDYIADVWMDGDAEGLEDETPIAELNIIDSAGIYDLVHYLQGEFRITVPLQDISLKNFRSVSTITALVDRLQKADRAAEEVGGAA	MQKKWLILTIIVLIYLPVTIDATVMHVATPSLSAALNLTANQLLWIIDIYSLIMAGLILPMGALGDRIGFKKLLFIGTAVFGVGSLAAAFSPTAYALIASRAILGLGAAMLIPATLSGIRNAFTEEKQRNFALGIWSTVGGGGAAFGPLVGGFVLEHFHWGAVFLINIPIILAVLVMIVMIIPKQQEKTDQPINLGQALVLVVAILSLIYSIKSAMYNFSVLTVVMFVVGISTLIHFIRSQKRATTPMIDLELFKHPVISTSIVMAVVSMIALVGFELLLSQELQFVHGFSPLQAAMFIIPFMIAISLGGPLAGICLNKWGLRRVSSLGILVSALSLWGLAQLNFSTDHFLAWTCMVFLGFSIEIALLASTAAIMSSVPPQKASAAGAIEGMAYELGAGLGVAIFGLMLSWFYSRSIILPAELPSNLIEKASISIGETMQLASNLENPLGGQLIVVAQQAFSYAHSWVLTLSAICFFLLTVFVWFSFPKKVN	18.70	gnl|BL_ORD_ID|2775|hsp_num:0	3280		
BGC0000257.1|Prodigiosin_30 # 41323 # 43239 # 1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.712	BGC0000257.1|Prodigiosin_30 	41323	43239	+	Loose	650	26.5646	vanO	36.96	3002913	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; van ligase	ATGACCCACATCATGACCGACCGTCCGGACACCGGCGCGATCCACCGGCAGGTGCTGGACATCGTGGCGGCACGCACCCTGTACGACGAGACGCATCTGCTGCCGGACAGTCACTTCGAGGGTGAGCTCGGCATCGACTCGATCGTGCTGGAGTCCATCCTCTCCTCGGTGAAGGAGCACTTCGGCATCGTGGGCGGGCTGCCGCCCGGACTGTCCACGATCAGGGAACTGGTCGACGCGGTGGCGCACGCGCTGGGTGCCGCGCCGGGCGCGGGCGCCGCGGCGCCCGGCGCCGCCGGTGCGCCGGCGGAGGAAGCCGGCGGGCCCGCGCTGGACGCCGTGCTGGCCGCCGCCATGCGGCAGACCCAGTACCAGCGCCACCAGCTGGACCCCGACGCGGACTTCGAGGGCGAACTCGGCATCGACTCGGTGGTACTCGCCTCCGTCGTCGCCGAGGCCGCGCAGGCCCTCGGTATCCCGGACGGCAGGGCGGACGCCGGCGGCGCGACGACGCTGCGCGGGCTGGCCGCCGTGCTCGGCGCCGTGGCGGGGACGGAGGCGGGCACCACCGCGGAACCGAGACCGCCCGAGCCCGCCGCCGCGGCCCCCGGGCCCGCGGCCCCCGCGCCGGCCGCGGGCGGCGACCCCGGCTGGGACAGCCGTTCCATGAAGGACTTCGTGGAGCAGCGCGACCCGGACCTGTTCGCCAAGGCCCGCAGCTTCGCCGTGTACCGCCGCCGGCGCGAGGAGGAACAGCTCTACTGGTACGGCATGCCGATGCACTCGCGCAGCGAGAACCGTGCACTGATCCACGACGAACTGACCGGCCAGAAGCGCGACTTCCTGATGTTCGCCTCGAACAACTACCTCGGGCTCGCCACTCACCCGAAGGTCATCGAGGCCGTCTGCGACGTCACCCGCATCTACGGCTCCACGCACACCGGCTCCCGCATCATCGGCGGCACCAACCACCACCACCTGCACAAGGAACTGGAGCGGCGGCTCGCGGCGTTCAAACAGCGGCCCGCCTGCATCGTGTACCCCGGCGGGTACTCGGCCAACCTGGGCGCCATCTCGGCGCTGGTGAGGAGCTACGACACGCTGCTGGTCGACAAGCTCAACCATATGAGCATCGTGGACGGCGGCCGTCTCTCGGGCGGCAACCGGCGCATCTACCAGCACAACGACATGGCCGACCTGGAACGGCTGCTCCAGCGCGAGGAGGGCCGGGGCACCGGCAAACTCATCGTGGTGGACGGCGTGTTCAGCATGCACGGCGACATCTGCGACCTGCCGGAGATCGTCCGGCTGGCCCAGCGGTACGGCGCGCGGGTGCTGGTCGACGACGCGCATGCCACGGGTGTACTGGGCGCACGCGGCACCGGGACGGCGGAGCACTTCGGGCTCAAGGGCCAGGTGGACCTGGAGCTCGGCACCATGAGCAAGACGCTGGCGGGGATGGGCGGCTTCGTGGTCGGTGACGAGGAGGTCATCGACTATCTGCGGTTCTACTCGAACTCGTACGTGTTCGCGGCGAACATCCCGGCGGGTGTGGCGGCGGGGCTGATCGCGTCCATCGACGTGATCGAGTCCGAGCCGGAGCGGATCGAGCGGCTGTGGGCCAACATCCGGATGCTGCGGGACCTGCTGCGCGGTGCGGGATTCGACCTGGAGCACACCGAGAGCGCGATCCTGCCGATCGTGGTGGGCGACGAGCGGCTGGCGATGGAGATGGGGCGCGCGGTGCGGGCCAGGGGGCTGTTCTGCCAGACCGTCGTCTTCCCCGGCGTCGCCGTGGGCGATGCCCGGCTGCGGATCAGCGTCACCTGCGAACACACCCCGGAAGACCTGGAGACCGCCGCCGGCATCTTCACCGAGGCCGCGCGTGAGACCGGCGTCCCCCTCGATCCGGCCTGA	MTHIMTDRPDTGAIHRQVLDIVAARTLYDETHLLPDSHFEGELGIDSIVLESILSSVKEHFGIVGGLPPGLSTIRELVDAVAHALGAAPGAGAAAPGAAGAPAEEAGGPALDAVLAAAMRQTQYQRHQLDPDADFEGELGIDSVVLASVVAEAAQALGIPDGRADAGGATTLRGLAAVLGAVAGTEAGTTAEPRPPEPAAAAPGPAAPAPAAGGDPGWDSRSMKDFVEQRDPDLFAKARSFAVYRRRREEEQLYWYGMPMHSRSENRALIHDELTGQKRDFLMFASNNYLGLATHPKVIEAVCDVTRIYGSTHTGSRIIGGTNHHHLHKELERRLAAFKQRPACIVYPGGYSANLGAISALVRSYDTLLVDKLNHMSIVDGGRLSGGNRRIYQHNDMADLERLLQREEGRGTGKLIVVDGVFSMHGDICDLPEIVRLAQRYGARVLVDDAHATGVLGARGTGTAEHFGLKGQVDLELGTMSKTLAGMGGFVVGDEEVIDYLRFYSNSYVFAANIPAGVAAGLIASIDVIESEPERIERLWANIRMLRDLLRGAGFDLEHTESAILPIVVGDERLAMEMGRAVRARGLFCQTVVFPGVAVGDARLRISVTCEHTPEDLETAAGIFTEAARETGVPLDPA	MSRLKVGVIFGGASEEHPVSIKSAREVARSLDTEKYEPFWIGITTGGEWKLCDGPDADWENRSARPAVLSPDRSVHGLLVMEQGGYETVRLDLVFPVLHGKLGEDGAIQGLLELAGIPYVGCDIQGSAVCMDKALAYIVAKSAGIATPSFWVVAENEKVDADHLRYPVFVKPARSGSSFGVSKVTREDELPNALSAARQYDSKVLIEEAVAGSEIGCAVMGELFGLITGEVDRVDLSHGFFRIHQEDSPETGSENSTFIVPADISDESRRLVQETAKAIYRTLGCKGLARVDMFLTDDGRVVLNEVNTMPGMTSYSRYPRMMAAAGLPISDMIDRLISMTMHGKKR	184.39	gnl|BL_ORD_ID|1653|hsp_num:0	1754		
BGC0000257.1|Prodigiosin_32 # 44931 # 45725 # -1 # ID=1_32;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.780	BGC0000257.1|Prodigiosin_32 	44931	45725	-	Loose	375	24.2534	tmrB	33.33	3003059	protein homolog model	n/a	n/a	nucleoside antibiotic	reduced permeability to antibiotic	tunicamycin resistance protein	GTGTACCGCTTCACGCCCGCCTCGGTACGGCGGGCGCTCGACGCCGGCCGCGCCGCCGCCGATCTGCACGCCTTCCTGGCCGCCCGGTCCCGCACACCCGTGCCGCAGCCGCTGACCTACCTGGTGGACGACGTGGCGCGGCGGCACGGCCGGCTCCGCGTCGGTGCCGCCTCCTCGTACGTGCGCTGCGACGATGACGCGCTGCTCGCCGAGATCCTCGCCGACCGCAGGTCCGCCCCGCTGCGGCTGCGGCTGCTGGCGCCGACCGTCCTCGCGTCGCCCGAGCCGCCGGACCAGCTGCTCGCCCGGCTGCGGGAGATGGGGTACGCGCCGGCTGCCGAGTCGGCCGACGGCGAGGTGCTGGTAGCGCGCCCCGATGCCCGCCGCACCCCGCCCCGTACGGCGCCGGAGCCGGTGCCGGACGGGCCGCCGGTGCCGGAGGCGACGCTGCTGCGCGCCGCCGTACGGGCGATCAGGGCGGGGGACCACGCGGCGACCGCGGCGCACAAGCCGAAGGCCCCGCCCGGGGCCCGTACGGCCCAGGGCCCGGCCGGCGGCGGCGACCTGCCGCGCACCTCGTCGCCGGACACGCTGGCCACCATGCAGTCGGCGGCGCTCACCGGCGCGGCCGTCTGGATCGGCTATGTGAACGCGGACGGCGCGGCCAGCCAGCGCGTCATCGCCCCGGTCCGGGTGGAGGGCGGCTTCGTGACGGCCTACGACCACACGGCCGACGAGGTGCGTACCTACCCGCTGCACCGCATCACGGGCGTGGCCGAACTGGCCGACGGCTGA	MYRFTPASVRRALDAGRAAADLHAFLAARSRTPVPQPLTYLVDDVARRHGRLRVGAASSYVRCDDDALLAEILADRRSAPLRLRLLAPTVLASPEPPDQLLARLREMGYAPAAESADGEVLVARPDARRTPPRTAPEPVPDGPPVPEATLLRAAVRAIRAGDHAATAAHKPKAPPGARTAQGPAGGGDLPRTSSPDTLATMQSAALTGAAVWIGYVNADGAASQRVIAPVRVEGGFVTAYDHTADEVRTYPLHRITGVAELADG	MIIWINGAFGSGKTQTAFELHRRLNPSYVYDPEKMGFALRSMVPQEIAKDDFQSYPLWRAFNYSLLASLTDTYRGILIVPMTIVHPEYFNEIIGRLRQEGRIVHHFTLMASKETLLKRLRTRAEGKNSWAAKQIDRCVEGLSSPIFEDHIQTDNLSIQDVAENIAARAELPLDPDTRGSLRRFADRLMVKLNHIRIK	134.01	gnl|BL_ORD_ID|1695|hsp_num:0	1794		
BGC0000257.1|Prodigiosin_33 # 45800 # 47296 # -1 # ID=1_33;partial=00;start_type=GTG;rbs_motif=ACC;rbs_spacer=15bp;gc_cont=0.812	BGC0000257.1|Prodigiosin_33 	45800	47296	-	Loose	525	31.187	OXA-724	25.7	3004837	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGGCCCCCGACCCCTGCCCGTACGGCACGCTCCGCGCGCTGCTGGCGGGCGATGCCGCCGCCCAGGACGGCGCGCCGCCGGAACCCGTGGACGTGTGCCTGCCGCGCGCCCTCCGCACGCTGCGCGACCGTGCCCTGCTGTGGGGCGCCGACGACCGGCTGCGGCTCGTGCGGACCGCACGCGAGGTGCTCGCGCCGGCGTCCGGCAGCCCGTCCCCCACCGGCCTCGGCCCGGCGCTCGCCGACGCGGCGGCGGGCATGTCGCCGGGCCGGCTCCAGGACATCCTGGCCGCGGCCGGGCTCGCCCCCACCCGTGACCCGGTGAGCGCGGTCGACGCGCTCGCCGCGCTGTTCACCGACCGGGACCGGCTGGGCAAGCTGCTCGGCGCCGCGCCGCCGGAGAGCCGCGCCGTGCTGGACCGGCTGGTGTGGGGCCCGCCGTACGGCGTGGCGGCGCACCGCGCCCCGGCGCCGCCGCTGCGCTGGCTGCTGGACCGCGGGCTGCTGCTGCCCGCCGGTGAACGCACCGTCGTACTGCCCCGTGAGGCCGCGCTCGGCCTGCGCGGCGGGCGGGCGCACCGCGTGCTCGAACCGCTGCCGCCCCCGTTGCGCGCCGGGCGCGCGCACCCGCCCGCCGCCGTGGACGGTACGGCGGCGGGGCAGGCGTTCGCCGCGCCGGGCGTGGTGGAGGAGCTGCTGGGCGGCTGGGAGGCGGAGCCGCCGCCGGTGCTGCGGGCGGGCGGCCTCGGCGTACGGGACCTGAAGCGCGCCGCGGCGGCGCTGGACGTACCGGAGCCCGAGGCCGCCTTCTGGATCGAACTCGCGTACAGTGCCGGGCTGCTCGCCTCGGACGGCGCGGCGGACGAGCGTTACGCGCCGACGCCGGGGTACGACGACTGGCTGCGCGATCCGCCGCACCGGCGGTGGGCCCGGCTGGTGTCGGCCTGGCTCGCCGCCAGCCGGGTGCCGGGCCTGGCGGGCGGGCGGGACGCGAAGGGGCGTCCGCTGGCCGCGCTGGGCCCTGGTCTCGACCGGGGGCCGGCCCCCGATGTACGGCACCGGGTGCTGGCGCTGCTGGGCGGGCTCGCCCCTGGCGAGGCCCCGGAGGCGGCGGCGGTGACGGGCCGGCTGGACTGGGAGCGCCCGCTGCGCGGCGCAGGGCGGAACGGCACCGGCACTGGCACCGGCACCGGCACCGGCACCGGCGGGAACGAGGACGGCGGGGGCGACCGGGACGGCGAGCCGCTGCGCACCCGGCTCGCCCGCTGGACGCTGGCCGAGGCCGAGCTGCTCGGCCTCACCGGCCGCGCCGCCCTCGCCTCGTACGCCCGCCAGCTGCTCCCCGGGGACCCGGCGGCCGGCCCCGAGGCCGCCGGTGACTCCTGGGGCCGGTGGTTCACCGCCGCCGAGCAGGACGCCGCGGTGGCCCGCGCGGCGGACGCGCTCGCCCCGCTGCTGCCGGAGCCGCTGGACCACGTGCTGCTCAGGCCGATCTGA	MAPDPCPYGTLRALLAGDAAAQDGAPPEPVDVCLPRALRTLRDRALLWGADDRLRLVRTAREVLAPASGSPSPTGLGPALADAAAGMSPGRLQDILAAAGLAPTRDPVSAVDALAALFTDRDRLGKLLGAAPPESRAVLDRLVWGPPYGVAAHRAPAPPLRWLLDRGLLLPAGERTVVLPREAALGLRGGRAHRVLEPLPPPLRAGRAHPPAAVDGTAAGQAFAAPGVVEELLGGWEAEPPPVLRAGGLGVRDLKRAAAALDVPEPEAAFWIELAYSAGLLASDGAADERYAPTPGYDDWLRDPPHRRWARLVSAWLAASRVPGLAGGRDAKGRPLAALGPGLDRGPAPDVRHRVLALLGGLAPGEAPEAAAVTGRLDWERPLRGAGRNGTGTGTGTGTGTGGNEDGGGDRDGEPLRTRLARWTLAEAELLGLTGRAALASYARQLLPGDPAAGPEAAGDSWGRWFTAAEQDAAVARAADALAPLLPEPLDHVLLRPI	MSRLLLSGLLGAGLLFSLPASAATGCFLYADGNGQALSSEGDCSSQLPPASTFKIPLALMGYDSGFLVDEEHPALPFKPGYDDWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQYVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPQEQARFLGKMVSGKLPVSAQTLQYTANILKVSESDGWQIHGKTGMGYPKKLDGSLNREQQIGWFVGWASKPGKQLIFVHTVVQKPGKQFASLKAKEEVLAALPAKLKTL	188.64	gnl|BL_ORD_ID|2673|hsp_num:0	3633		
BGC0000257.1|Prodigiosin_34 # 48267 # 48884 # 1 # ID=1_34;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.840	BGC0000257.1|Prodigiosin_34 	48267	48884	+	Loose	600	26.5646	vanHB	35.59	3002943	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	TTGACCGGCTCGGCGACCCGGCGGACCTGGTGGCGGCGGCGAACGGCGGTACGCCGCCTGCGGTCCCCCGCGGCGGGCCGGGTATCGGGGGCCGGCGACGGCAGCACCGGCACGGCCCGCGGTGCTTCGCTGCCGCGCCCGGCCGCGGACCCGCCGCCCCGGGCGCCGCGTCCGCGGCTGCCCCGGCTGCCGCAGCAGGAGCGCAAGGAGCCGGGCACCGGCCGGCGTGCGTCGCCGGTCCCCGAGCCGCCCGCGGAGCCGCCGCCCACCGCGGCGTACGGCGCGTCGCCGCCGCATCTGGCAGGCATGGACGAACTGGGGCCGATGGAGAGCGACCCGGACTGGTGGCGTACCGGTCCCCTCGTCCCGTTCGGCTCCGGGGGCCCGGCTGCCGGCGGCGGGAGCGGCGGCGCGGGCTCCGGGAGCCGCACGGGGGCCGGGCAGATGCCCGGCTTCTACGGCGGCATCGAGCTGCCGGAGCTGCTGAAGCCGCCGCGGCGGGGCCCGCCGGGCGCCCCGCGGCGGCGCCCGGCGCGCCGGAGGCGCCCGCGCCCGCCGCGGGCACGGGTGCCCCCGGCGGCGGGCCGGCCCGCGCCCGCCGCCGAGAGCGGCGGCTAG	MTGSATRRTWWRRRTAVRRLRSPAAGRVSGAGDGSTGTARGASLPRPAADPPPRAPRPRLPRLPQQERKEPGTGRRASPVPEPPAEPPPTAAYGASPPHLAGMDELGPMESDPDWWRTGPLVPFGSGGPAAGGGSGGAGSGSRTGAGQMPGFYGGIELPELLKPPRRGPPGAPRRRPARRRRPRPPRARVPPAAGRPAPAAESGG	MRKSMGITVFGCEQDEANAFRTLSPDFHIIPTLISDAISADNAKLAAGNQCISVGHKSEVSEATILALRKVGVKYISTRSIGCNHIDTTAAERMGISVGTVAYSPDSVADYALMLMLMAIRGAKSTIHAVAQQNFRLDCVRGKELRDMTVGVIGTGHIGQAVVKRLRGFGCRVLAYDNSRKIEADYVQLDELLKNSDIVTLHVPLCADTRHLIGQSEIGEMKQGAFLINTGRGALVDTGSLVEALGSGKLGGAALDVLEGEDQFVYTDCSQKVLDHPFLSQLLRMPNVIITPHTAYYTERVLRDTTEKTIRNCLNFERSLQHE	63.47	gnl|BL_ORD_ID|586|hsp_num:0	626		
BGC0000257.1|Prodigiosin_13 # 15119 # 22489 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.761	BGC0000257.1|Prodigiosin_13 	15119	22489	+	Loose	750	84.3445	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	31.68	3003463	protein variant model	F413L	n/a	isoniazid	antibiotic target alteration	antibiotic resistant kasA	GTGCTGCGCCGGCACGCGGGACACCGCCCGGACGCCCTCGCCTACCGCTTCCTGACCGGCGACGCCGGTGAGCCCCCGCAGTCCTGGACGTACGCCGACCTGGACGCCCGCGCCCGCACCATCGCCGCGCGCCTCCAGGAGGACGGCGTCCGTGACGTGCCGGTGCTGCTGCTGCACCCGCCGGGCCTGGAGTACGTCGCCGCCTTCCTCGGCTGCCAGTACGCCGGGGCCATCGCGGTGCCCGCGTACCCGCCGGACGCCGGGCGGTTCGGCCAGACCGTGCCCCGGCTCGCCGCCATCGCCAGGGACACCAGGGCCACCCACGCGCTCACCACGGACGCCTTCCGCCGGATCACCGGGGAGCGGCAGCAGGAGCTGACCGCGCTGGGCCTGGGCGGCCTGACCTGGGTGGCCACCGACGCGCTGGACGGTGCCCGCGCCGACACCTGGCGGCACCCGGGCACCGGCGGTGACGCGGTCGCCTTCCTCCAGTACACCTCGGGCTCCACCGCCACCCCCAAGGGCGTGATCGTCGGCAGCGACAACCTGCTGGCCAACCTGCGCTCCATCCACAGCTACCTGGAGCACGACGAGCAGTCGCAGCTGGTGTCCTGGCTGCCCCCGTACCACGACATGGGCCTGATCGGCGGCATCCTGGAGCCGCTGTACGGCGGCTACCCGTCGCACCTGATGGCGCCCATGACCTTCCTGCGCAGCCCCCGGCTGTGGCTCGCGACGCTGTCCGAGACCGGTGCCTGCACCAGTGTGGCGCCGAACTTCGGCTTCGAGCACTGCATCCGCCGGATCCGCCCCGAGCAGCGGGAGGGCCTCGACCTGCGGCACTGGCGGCTGGCGCTGGACGGCGCCGAGCCGGTGCGCGGTGACACGCTGGAGCGGTTCGCCGAGCTGTTCGCGCCGGCCGGGTTCGACGCCCGTGCCCTGATGCCCTGCTACGGGCTGGCCGAGGCGACGCTGATGGTCACCGGCATCGGGCCGCGCGAGCGGTTCCGCACCACGGCCTTCGACTCCGGGTCGCTGGAGGCGGGTGTTCCGGTGCCCGCGGGGCCCGGCACCCGGCGGACCACGGACGTCGTCAGCTGCGGCGTGCCCATCCCGGACGTGGAGGTGGCCGTGGTCGACCCGGCCACCGGGCGGCGCACGGAGCCGGGCGGCGTCGGGGAGATCTGGATCGCGGGCCCGAACGTCGCGCGGGGCTACTGGGGGCGCACCGACGCCACCGAGGAGTCCTTCCGCGCGGTGATCGAGGGCGAGCCGGAGCGCGCCTGGATGTGCAGCGGTGACCTCGGCTTCGTACGGGACGGTGAGCTGTCCGTGGTCGGCCGGATCAAGGACGTCATCGTCCTGGAGGGCCGCAACCACCACCCGCACGACATCGAACTGACCGTGGAACGCGCCTGCGAGGTGCCGCGCGCGGGCGGCGCCGTCGCGTTCGGCTCCCAGGTGGGCGGCGTGGAACGGCTGATGGTCGGCTTCGAGGTGGATCCGCGGCAGGTGCCTGACCCGGCGCGGCTGCTGGCCACGCTGCGGGCGGCGGTGGCCGCCGAGCACGAGGCATCGCCGCACACCGTGGCGCTGCTGCGGAAGGGTTCGCTGTCCAAGACGACCAGCGGGAAGATCCAGCGGCGGGCGTGCCGGGCGGCGTTCGAGAGCTTCGAGCTGACGGTGCTGGCCGCCAGCGTGTCCCGCGACCTGGACCCCGGCGGGGGCGCGGCGCAGGACGCGCCGCCGCAGCTGTCCGCGGCGGAGCGCCGGGCGCGGGCACTCGCCGCGGTCGGCGAGGCGCTGCGCGCGGCCGGGGCGGCGGACGGCGGCGGCAGCAGCGAAGACGGCGCGTCCGGCGGCCGTACGTTCGCGGATCTGGGCCTCGGCTATCCGGCGGTCACCGCCTGTGCGGCGGACGTCGAACGGCGCCTGGGCGTGCGGATCCCGGTCGGTGAGCTGCTGGTACGGCCCCGGGTGGACACGCTTGTCGCGCTCTGCCTCGGCGAGCGCCCGGGCCAGGACGCGGGCCAGGACGCGGAGCCCGCCCCCGCGGCGGCCGGCGCGGGCGGCACCGGAGCCGCCCCCGGAGCCGCCCCCGAGTCCGGCGACACGTCCGGCGCGTCCGCGCCGCGGCGTCCGCAGCCCGATGCCCGGGAGATCGAGGCGTGGCTGGTCGGACGTGTCGCCCACTGCCTCGGCCTGCCCGAGGAGACCATCGACACCCGGCAGCCGTTCGCGGCCATCGGGCTGGACTCCAAGCAGGCCACCGCGATCGCCGACGAGCTGGGCCGCTGGCTGGACCGCGCCGTCACGCCCGGCCTGGTCTTCGACCATCCGACCGTCGAGCGGATGGCCGCGCACCTGAGCGCCGGCGCCCCGCGCGCCGCCGCCACGCGGGACCGCGCCCCTGAGCGCGCGCCCGCACCCGCGGGCGCCCCGGCGGATCCGGCCGGGGTGCAGGATCCCATCGCCATCGTCGGCATGGCCTGCCGGTTCCCCGGCGCCCCCGACGTGCCGAGCTTCTGGCGGCTGCTCACCGACGCCCGCGACGCCGTCGGCGAGGTGCCCGCGGACCGCTGGGACGCGCGCGCGGTGGACGCCCCCGGGTACGGCGGATTCATCGACGACGTCGGCGAGTTCGACCCGCGGTTCTTCGGCCTGTCCGCGCGCGAGGCGGAACGCATGGACCCGCAGCAGCGGCTGCTCCTCGAACTGGGCTGGCAGGCGTTCGAGGACGCCGGGACCGCCCCCGGCTCGCTGGCCGGCAGCGACACCGGCGTGTTCGTCGGCATCAGCAGCAGCGACTACGCGGAATTCCAGATGCGGCGGCTGGACACCGTCGACGTCTACGGCGCCACGGGCAACGCGCACGCCATCGCCGCGAACCGGCTGTCCTACTTCCTCGACCTGGCCGGGCCCAGCCTGGCCCTCGACACCGCCTGCTCCTCGTCACTGGCCGCGGTGCACGCCGCCTGTCAGAGCCTGCGCGCCGGTGAGTGCACCAGCGCGCTGGCGGGCGGCGTCAACCTGATGCTCACACCGGGCCTCTCGGTGGCCTTCGCGGCCGGCCGGATGCTGGCGCGGGACGGCCGCTGCCGGGTGTTCGACGATGCCGCGGACGGCTATGTACGCGGCGAGGGCGCCGGGCTGGTCTGCCTCAAGCCGCTGTCGGCGGCGCTGGCGGACGGCGACCGGGTATACGCCGTGATCCGCGGCTCGGGCCTGGGCCACGGCGGCCGCAGCAACGGACTGACCGCACCCCGCGGCTCCGCCCAGCGCGCGGTCATCGAGCGCGCGCTGCGCACCTCCGGACTGCGCCCCGACCAGATCGGGTACGTGGAGGCACACGGCACCGGCACCCCGCTCGGCGACCCCGTGGAGTGGGAGGCGCTGGCCGAGGTGTACGGGCAGCGGGCCAGGGGCAAGGAACCCTGCCTGGTCGGCTCGGTGAAGAGCAACATCGGGCACCTGGAGGCGGCGGCCGGCATCGCCGGGCTGATCAAGACCGCGCTGGTGCTGCACCACGGGCACGTGCCGCCGCAGCTCCACCTCAGCACGCGCAACCGGCGGATCTCCTTCGAGGGTTCGGGCCTGACCGTGGCCACGGCCGCCCGCGAGCTGCCGCGCGACGCCGGCGCGCCGGCGCGTGCCGGGGTCAGCTCGTTCGGCTTCGGCGGACAGAACGCGCATCTGGTGCTGGAGGCCGGCACCGGGCCGGGCCCGGACACCACGGACGCGGACGCCGCGCAGGACGCCGCGCAGGGCACCGGTGCCGCCGCGGGCCCGCAGCCGCACGCGCTGTGCCTGTCGGGCCACACGGCCACCGCGCTGGCCACCCTCGCCCGCCGCTACCGCACCCACCTGGCCGCGCACCCCGGCGTGCCGCTGGGCGAGCTGTGCCGCACCGCGAACACCGGGCGCACGCACCTGGCGCACCGGGCCGTGCTCACCGCGGATTCCACCGAGGCGCTGGACGGCGCCCTGGAGCGGCTGGCGCAGGGCGGCGCGTCGCCCGGCATCGCGCGGGGCGACCTCAGCGGGGGCACGGCGGCGCCGCGCACGGCGTTCCTGTTCTCCGGGCAGGGCAGCCAGTACCCCGGCATGGCGCGGGCGCTGTACCGCACGCGGCCGGTGTTCGCGCGTGCCCTGGACGAGTGCGACGAGGTGCTGCGCCCGCTGCTGGACGTCTCGCTGCCCGCGCTGCTGTTCGACGAGGACGGCTCGGGGGACGGTTCCGCGGGCGGCGGCCGGCTCGCCCGTACCCGCTACTGCCAGCCCGCGCTGGTGGCGCTGGAGATCTCGCTCGCGCGGCTGTGGCAGTCGCTCGGCGTGCGCCCGGCGGCCGTGCTGGGGCACAGCGTGGGCGCGCTGTCCGCCGCCTGCGTCGCCGGAGTGCTGTCCACCGAGGACGCGCTGACGCTCGCGGCGGCCCGCGGGCGGTACATGGACGAGCAGCCGGGCGACGGCGCCATGATCGCCTGCATCGGTGACCAGGACCGGATCAGGGCCGTCGCCGGTCGGTACGCCTCGGTCGGCATCGCCGCGGTCAACACCCCCGAGCACCTGGTGCTGTCCGGCGCGGCGGGCGAGATCCGCGGCGCGGGCGGGGAACTGGCCGGGCACGGGGTCACGGTGCGTCCGCTCCGGGTCTCGCACGCCTTCCACTCCACGCTGATGAGCGGTGCCGCCGCCCCGCTGCGGGACGCCGCGCTGCGGCTGCGGCACGGCACGCCCGCCGTGCCCTGGGTGTCCGACGCCACCGGCGAGGTGGTGGACACCGTGGACGCCGGCTTCTGGGCCGAGCACCTGCTCGGCACGGTGCGCTTCGCGGACGGCTTCGCCACGCTGCGCGGCCTGGGCTGCGACGCGTTCGTGGAGATCGGCCCGCACCCGACCCTGATCGACCTCGGCCGCGCCATGCTCGGCGCGGGTCCGCCCGGCGAGCTGGGCCGCACCCTGCTGCTGCCCTCGCTGCGGCGCGGCGACGACACCGGGGAGCCGCTGCTGCGGTCGCTCGGGCGGCTGCACTGCGCGGGCGCCCCGGTCGACTGGGCGGCGCTTGAGCCGGGGCCGCGGCGGGCGGGCGCGCCCGCGCCGCACACGGTCTTCGAGCGGCAGCGGTACTGGATGACGCCCCCTGACCCGGCGGCGCCCGCGGTGCCGGGGCCCGCCCCCGCCCGTGCCGCCGCCCATGCCCATGCCAACGGCCAGGCCGCTCACCCGGGCGCCAGGCCGGTCACCAGCCACAGCAACGGAGGCCCGGTGCAGCCGAACGGACAGCCGAACGGACATCCGAGCGGTGGGGCGTCCGCCCCGTACGGCGCGGCCAACGGAACGCCCGGCGCGGGCACCGCCCAGCACACCGCCGCCCAGCACACCGCCGCCCAGCTCACCGCCACTCAGCTCACCGCGCACGCCGCCACCCACCAGGGCAACGGTGCCGTGAGCCAGGCACGGCCCGCGCCGGGCGTGCTCGGCGCCTCGGCGGCCCTGGACCACGCGCCCGGCGGGGCGCCGTACCCGCTGCCCCGGGTGCCGGGTGTGCCGGGCATGCCCGCGCCGTACGGTGCGCAGCCGGCGCCGCAGCACGCCCCCGCGCCGCACGCCGCCCCGGAACCGGCGGCCGGCGCCCAGCAGTTCGTGCTCAGCCAGATCGCGCAGATCACCGGGTTCCCGGCGCACGAACTGGCCGTGCACGCCCGGCTCGGCGCGGACCTCGGGTTCGACTCGCTGATGCGCAGCGAGCTGGAGCGCCGGATCGCCCAGCAGTACCCGGGGCAGCTGGAGGAGCTGCGCCGGGGCCTGCCGGAGGACCCGGCGGTGGAGCAGATCCTCGGGGTGCTCACGTCGGCGCCCGCCGCGCAGGGCGCGCCGCAGCCGGCGGGCCACCCGCAGCCGCCGCACCAGCCGGCCGCACAGCCGCAGCCGTACCCGCAGCCGCAGCCGTACCCGTACCTGTATGCCGGCGCGCCGGTGCCCATGGCCGCGCACCCCGGATACCCGGGATACCCCGCCTACATGATGTACCCCGGGCACCCCGGGTACGCGCCCGCGTACGCCCCGGGAGCCCCGCACGCCCCGCAGTTCGCCGCCCCGCCGCCCCCGGCGCAGTCCGTACCGGCCGCGCCCGCCGCCCCGCCGGACGGTGCCGACGGCGCGCAGAACGGCGCGGCGGTGGTCCCCGAGCGCTCCTTCGAGGAGTCCGCCGAGTACCTGGAGCTCCAGGAGCGCCGCCGCCGGGCCACGGCCGGCGGGCTGAACCCGTACGGCCGGCTGCACGACGGCCACAACGCCGCCGCCGCCGAGATGGCGGGCCGCAGGCTGCTGAACTTCGCCGCGTTCAACTTCCTCGGCCTCTCCCACCACCCCCGGGTGATCCAGGCCGCGAAGGACGCCGTCGACCGGTACGGCACCTCCGCCTCCGCCACCCCGGTGCTGTTCGGCGAGACACCGCTGCACCATGAACTGGAGGACGAGCTCGCCTCCTTCCTCGGCACCGAAGGCGCGATCGTCTTCCCCGGCGGCCACGCGACCAACGTCGCCACCGTCGGCCATCTGCTCGGCCCGCAGGACCTGGTGCTGCACGACGAGTGGATCCACGACAGCACCGTGCGCGGCGCGGTCCTCTCCGGCGCGCGCCGCCGCCCGTTCCCGCACAACGACTTCCGCGCCCTTGAGCGCCTCCTGGAGCGGCTGCGCGGCCAGCACCGGCGGGTACTGATCGTGATCGAGGGCGTCTACAGCCAGGACGGCGACCTGCCGGACCTGCCCGCGTTCATCGACGTGAAGAAGCGCCACGACGCCCTGCTGATGATCGACGAGGCGCATTCGATCGGCGTGCTCGGCGGCACGGGCCGCGGCATCGGCGAGTACTACGGCACCGACCGCGGCGACGTCGACCTGTGGATGGGCACCCTGAGCAAGGCGCTCGGCAGCCTCGGCGGCTACGTCGCGGCCCGCCGCAGCCTGATCGACTACCTCAAGTACACGACGCCGCTCTACATCTTCAGCACCGGCATCTCGCCCGGCAACGCGGGCGCCGCCCTGGAGGCCGTCCGGGTGCTGCGGGAGGAGCCGGAGCGCGTCACCCGGGTGCGGGAGCTGGCCGAGTACTTCCGTGACCTGACTGCCCGTGCCAGGGGCCTGGACACCGGCGTGTCCCGCGAGTCGGCCATCATCCCCGTCCTCATCGGGGACTGGCAGCGGGCCATGGAGGTCTCCAACCGGCTGCTGGAACAGGGCGTCAACGTGATGCCGATCGGCTATCCGGCCGTCGCCCGCGACCAGTCCAGACTGCGCTTCTTCATCAACACCGACCACCGTGAATCCGACCTCGACCACGCACTCGACCTGCTGGGGCGGCCATGA	MLRRHAGHRPDALAYRFLTGDAGEPPQSWTYADLDARARTIAARLQEDGVRDVPVLLLHPPGLEYVAAFLGCQYAGAIAVPAYPPDAGRFGQTVPRLAAIARDTRATHALTTDAFRRITGERQQELTALGLGGLTWVATDALDGARADTWRHPGTGGDAVAFLQYTSGSTATPKGVIVGSDNLLANLRSIHSYLEHDEQSQLVSWLPPYHDMGLIGGILEPLYGGYPSHLMAPMTFLRSPRLWLATLSETGACTSVAPNFGFEHCIRRIRPEQREGLDLRHWRLALDGAEPVRGDTLERFAELFAPAGFDARALMPCYGLAEATLMVTGIGPRERFRTTAFDSGSLEAGVPVPAGPGTRRTTDVVSCGVPIPDVEVAVVDPATGRRTEPGGVGEIWIAGPNVARGYWGRTDATEESFRAVIEGEPERAWMCSGDLGFVRDGELSVVGRIKDVIVLEGRNHHPHDIELTVERACEVPRAGGAVAFGSQVGGVERLMVGFEVDPRQVPDPARLLATLRAAVAAEHEASPHTVALLRKGSLSKTTSGKIQRRACRAAFESFELTVLAASVSRDLDPGGGAAQDAPPQLSAAERRARALAAVGEALRAAGAADGGGSSEDGASGGRTFADLGLGYPAVTACAADVERRLGVRIPVGELLVRPRVDTLVALCLGERPGQDAGQDAEPAPAAAGAGGTGAAPGAAPESGDTSGASAPRRPQPDAREIEAWLVGRVAHCLGLPEETIDTRQPFAAIGLDSKQATAIADELGRWLDRAVTPGLVFDHPTVERMAAHLSAGAPRAAATRDRAPERAPAPAGAPADPAGVQDPIAIVGMACRFPGAPDVPSFWRLLTDARDAVGEVPADRWDARAVDAPGYGGFIDDVGEFDPRFFGLSAREAERMDPQQRLLLELGWQAFEDAGTAPGSLAGSDTGVFVGISSSDYAEFQMRRLDTVDVYGATGNAHAIAANRLSYFLDLAGPSLALDTACSSSLAAVHAACQSLRAGECTSALAGGVNLMLTPGLSVAFAAGRMLARDGRCRVFDDAADGYVRGEGAGLVCLKPLSAALADGDRVYAVIRGSGLGHGGRSNGLTAPRGSAQRAVIERALRTSGLRPDQIGYVEAHGTGTPLGDPVEWEALAEVYGQRARGKEPCLVGSVKSNIGHLEAAAGIAGLIKTALVLHHGHVPPQLHLSTRNRRISFEGSGLTVATAARELPRDAGAPARAGVSSFGFGGQNAHLVLEAGTGPGPDTTDADAAQDAAQGTGAAAGPQPHALCLSGHTATALATLARRYRTHLAAHPGVPLGELCRTANTGRTHLAHRAVLTADSTEALDGALERLAQGGASPGIARGDLSGGTAAPRTAFLFSGQGSQYPGMARALYRTRPVFARALDECDEVLRPLLDVSLPALLFDEDGSGDGSAGGGRLARTRYCQPALVALEISLARLWQSLGVRPAAVLGHSVGALSAACVAGVLSTEDALTLAAARGRYMDEQPGDGAMIACIGDQDRIRAVAGRYASVGIAAVNTPEHLVLSGAAGEIRGAGGELAGHGVTVRPLRVSHAFHSTLMSGAAAPLRDAALRLRHGTPAVPWVSDATGEVVDTVDAGFWAEHLLGTVRFADGFATLRGLGCDAFVEIGPHPTLIDLGRAMLGAGPPGELGRTLLLPSLRRGDDTGEPLLRSLGRLHCAGAPVDWAALEPGPRRAGAPAPHTVFERQRYWMTPPDPAAPAVPGPAPARAAAHAHANGQAAHPGARPVTSHSNGGPVQPNGQPNGHPSGGASAPYGAANGTPGAGTAQHTAAQHTAAQLTATQLTAHAATHQGNGAVSQARPAPGVLGASAALDHAPGGAPYPLPRVPGVPGMPAPYGAQPAPQHAPAPHAAPEPAAGAQQFVLSQIAQITGFPAHELAVHARLGADLGFDSLMRSELERRIAQQYPGQLEELRRGLPEDPAVEQILGVLTSAPAAQGAPQPAGHPQPPHQPAAQPQPYPQPQPYPYLYAGAPVPMAAHPGYPGYPAYMMYPGHPGYAPAYAPGAPHAPQFAAPPPPAQSVPAAPAAPPDGADGAQNGAAVVPERSFEESAEYLELQERRRRATAGGLNPYGRLHDGHNAAAAEMAGRRLLNFAAFNFLGLSHHPRVIQAAKDAVDRYGTSASATPVLFGETPLHHELEDELASFLGTEGAIVFPGGHATNVATVGHLLGPQDLVLHDEWIHDSTVRGAVLSGARRRPFPHNDFRALERLLERLRGQHRRVLIVIEGVYSQDGDLPDLPAFIDVKKRHDALLMIDEAHSIGVLGGTGRGIGEYYGTDRGDVDLWMGTLSKALGSLGGYVAARRSLIDYLKYTTPLYIFSTGISPGNAGAALEAVRVLREEPERVTRVRELAEYFRDLTARARGLDTGVSRESAIIPVLIGDWQRAMEVSNRLLEQGVNVMPIGYPAVARDQSRLRFFINTDHRESDLDHALDLLGRP	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	590.38	gnl|BL_ORD_ID|2018|hsp_num:0	1943		
